Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Bladder Cancer, January 2019

Free Subscription


Retrieve all available abstracts of the following 396 articles:
HTML format


Single Articles

  1. NESI G, Galli IC, Amorosi A, Santi R, et al
    Environment and urinary bladder cancer. A historical perspective.
    Pol J Pathol. 2019;70:21-25.
    Abstract     Related articles   

  2. ZHANG Z, Xu H, Ji J, Shi X, et al
    Heterogeneity of PTEN and PPAR-gamma in cancer and their prognostic application to bladder cancer.
    Exp Ther Med. 2019;18:3177-3183.
    Abstract     Related articles   

  3. SIM WJ, Iyengar PV, Lama D, Lui SKL, et al
    c-Met activation leads to the establishment of a TGFbeta-receptor regulatory network in bladder cancer progression.
    Nat Commun. 2019;10:4349.
    Abstract     Related articles   

  4. KLEN R, Salminen AP, Mahmoudian M, Syvanen KT, et al
    Prediction of complication related death after radical cystectomy for bladder cancer with machine learning methodology.
    Scand J Urol. 2019 Sep 25:1-7. doi: 10.1080/21681805.2019.1665579.
    Abstract     Related articles   

  5. BAUMGART S, Meschkat P, Edelmann P, Heinzelmann J, et al
    MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
    J Cancer Res Clin Oncol. 2019 Sep 24. pii: 10.1007/s00432-019-03035.
    Abstract     Related articles   

  6. DATTA NR, Stutz E, Puric E, Eberle B, et al
    A Pilot Study of Radiotherapy and Local Hyperthermia in Elderly Patients With Muscle-Invasive Bladder Cancers Unfit for Definitive Surgery or Chemoradiotherapy.
    Front Oncol. 2019;9:889.
    Abstract     Related articles   

  7. ABUDUREXITI M, Xie H, Jia Z, Zhu Y, et al
    Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer.
    Front Oncol. 2019;9:856.
    Abstract     Related articles   

  8. DAZA-CAJIGAL V, Albuquerque AS, Pearson J, Hinley J, et al
    Loss of Janus Associated Kinase 1 Alters Urothelial Cell Function and Facilitates the Development of Bladder Cancer.
    Front Immunol. 2019;10:2065.
    Abstract     Related articles   

    Lymph Node Dissection for Advanced Bladder Cancer: Is There a Role?
    Eur Urol Focus. 2019 Sep 21. pii: S2405-4569(19)30284.
    Abstract     Related articles   

  10. PARIKH RB, Adamson BJS, Khozin S, Galsky MD, et al
    Association Between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer.
    JAMA. 2019;322:1209-1211.
    Abstract     Related articles   

  11. HOU G, Xu W, Jin Y, Wu J, et al
    MiRNA-217 accelerates the proliferation and migration of bladder cancer via inhibiting KMT2D.
    Biochem Biophys Res Commun. 2019 Sep 20. pii: S0006-291X(19)31750.
    Abstract     Related articles   

  12. LUO Y, Dong Y, Liang S, Yuan L, et al
    CpG Oligodeoxynucleotide Promotes Apoptosis of Human Bladder Cancer T24 Cells Via Inhibition of the Antiapoptotic Factors.
    Technol Cancer Res Treat. 2019;18:1533033819873636.
    Abstract     Related articles   

  13. LI W, Li Y, Sun Z, Zhou J, et al
    Comprehensive circular RNA profiling reveals the regulatory role of the hsa_circ_0137606/miR1231 pathway in bladder cancer progression.
    Int J Mol Med. 2019 Sep 17. doi: 10.3892/ijmm.2019.4340.
    Abstract     Related articles   

  14. YANG C, Sun X, Wang H, Lu T, et al
    Metabolomic profiling identifies novel biomarkers and mechanisms in human bladder cancer treated with submucosal injection of gemcitabine.
    Int J Mol Med. 2019 Sep 23. doi: 10.3892/ijmm.2019.4347.
    Abstract     Related articles   

  15. SHAN L, Liu W, Zhan Y
    Sulfated polysaccharide of Sepiella maindroni ink targets Akt and overcomes resistance to the FGFR inhibitor AZD4547 in bladder cancer.
    Aging (Albany NY). 2019;11.
    Abstract     Related articles   

  16. LIU Y, Xiong S, Liu S, Chen J, et al
    Analysis of Gene Expression in Bladder Cancer: Possible Involvement of Mitosis and Complement and Coagulation Cascades Signaling Pathway.
    J Comput Biol. 2019 Sep 23. doi: 10.1089/cmb.2019.0237.
    Abstract     Related articles   

  17. MORINAGA R, Kawahara T, Kuroda S, Inayama Y, et al
    Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer.
    Case Rep Oncol. 2019;12:603-607.
    Abstract     Related articles   

  18. BHUSHAN S, Ray RS, Prakash J, Singh GN, et al
    Global Versus Indian Perspective of Pioglitazone-induced Adverse Drug Reactions Including Bladder Cancer: A Comparative Retrospective Pharmacovigilance Analysis.
    Clin Ther. 2019 Sep 19. pii: S0149-2918(19)30422.
    Abstract     Related articles   

  19. ORTIZ-BRUCHLE N, Muders M, Toma M, Esposito I, et al
    [Status of the availability and use of next generation sequencing (NGS) in bladder cancer-a questionnaire within the uropathology working group].
    Urologe A. 2019 Sep 20. pii: 10.1007/s00120-019-01046.
    Abstract     Related articles   

  20. HU X, Xiong SC, Dou WC, Shao YX, et al
    Minimally invasive vs open radical cystectomy in patients with bladder cancer: A systematic review and meta-analysis of randomized controlled trials.
    Eur J Surg Oncol. 2019 Sep 13. pii: S0748-7983(19)30808.
    Abstract     Related articles   

  21. JANISCH F, Yu H, Vetterlein MW, Dahlem R, et al
    Do Younger Patients with Muscle-Invasive Bladder Cancer have Better Outcomes?
    J Clin Med. 2019;8.
    Abstract     Related articles   

  22. MOSCHINI M, Stabile A, Mattei A, Montorsi F, et al
    Enhanced recovery after surgery (ERAS) in radical cystectomy patients: from consensus to evidences.
    Int Braz J Urol. 2019;45:655-657.
    Abstract     Related articles   

  23. BASATAC C, Aktepe F, Saglam S, Akpinar H, et al
    Synchronous presentation of muscle-invasive urothelial carcinoma of bladder and peritoneal malign mesothelioma.
    Int Braz J Urol. 2019;45:843-846.
    Abstract     Related articles   

  24. CASTELLANI D, Gasparri L, Claudini R, Pavia MP, et al
    Iatrogenic foreign body in urinary bladder: Holmium laser vs. Ceramic, and the winner is....
    Int Braz J Urol. 2019;45:853.
    Abstract     Related articles   

  25. LI D, Jiao W, Liang Z, Wang L, et al
    Variation in energy metabolism arising from the effect of the tumor microenvironment on cell biological behaviors of bladder cancer cells and endothelial cells.
    Biofactors. 2019 Oct 3. doi: 10.1002/biof.1568.
    Abstract     Related articles   

  26. LIU J, Zhang Y, Zeng Q, Zeng H, et al
    Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes.
    Sci Adv. 2019;5:eaaw6499.
    Abstract     Related articles   

  27. SIMON M, Elkayam N, Smerling J, Marcelin M, et al
    Opportunistic Disease or Metastatic Lesions: A Rare Finding in a Patient with Bladder Cancer.
    Curr Urol. 2019;13:54-56.
    Abstract     Related articles   

  28. BARRY KH, Jones RR, Cantor KP, Freeman LEB, et al
    Ingested nitrate and nitrite and bladder cancer in Northern New England.
    Epidemiology. 2019 Sep 30. doi: 10.1097/EDE.0000000000001112.
    Abstract     Related articles   

  29. HUANG Y, Wang H, Fu S, Luan T, et al
    Association of rs8444 polymorphism in the LASS2 3'-UTR and bladder cancer risk in Chinese population.
    Eur J Cancer Prev. 2019 Oct 1. doi: 10.1097/CEJ.0000000000000551.
    Abstract     Related articles   

  30. LIAO S, Ou M, Lai L, Lin H, et al
    Integrated analysis of quantitative proteome and transcriptional profiles reveals abnormal gene expression and signal pathway in bladder cancer.
    Genes Genomics. 2019 Oct 1. pii: 10.1007/s13258-019-00868.
    Abstract     Related articles   

  31. MAO F, Niu XB, Gu S, Ji L, et al
    The association between matrix metalloproteinase-7 genetic variant and bladder cancer risk in a Chinese Han population.
    Clin Exp Med. 2019 Oct 1. pii: 10.1007/s10238-019-00582.
    Abstract     Related articles   

  32. ZHOU HQ, Liu MS, Deng TB, Xie PB, et al
    The TGF-beta/Smad Pathway Inhibitor SB431542 Enhances The Antitumor Effect Of Radiofrequency Ablation On Bladder Cancer Cells.
    Onco Targets Ther. 2019;12:7809-7821.
    Abstract     Related articles   

  33. QUAN Y, Lei H, Wahafu W, Liu Y, et al
    Inhibition of autophagy enhances the anticancer effect of enzalutamide on bladder cancer.
    Biomed Pharmacother. 2019;120:109490.
    Abstract     Related articles   

  34. MAKBOUL M, Farghaly S, Abdelkawi IF
    Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application.
    Br J Radiol. 2019 Oct 1:20190401. doi: 10.1259/bjr.20190401.
    Abstract     Related articles   

  35. FU W, Wu X, Yang Z, Mi H, et al
    The effect of miR-124-3p on cell proliferation and apoptosis in bladder cancer by targeting EDNRB.
    Arch Med Sci. 2019;15:1154-1162.
    Abstract     Related articles   

  36. HAN N, Yuan F, Xian P, Liu N, et al
    GADD45a Mediated Cell Cycle Inhibition Is Regulated By P53 In Bladder Cancer.
    Onco Targets Ther. 2019;12:7591-7599.
    Abstract     Related articles   

  37. ALANEE S, Deebajah M, Chen PI, Mora R, et al
    Using adaptive genetic algorithms combined with high sensitivity single cell-based technology to detect bladder cancer in urine and provide a potential noninvasive marker for response to anti-PD1 immunotherapy.
    Urol Oncol. 2019 Sep 27. pii: S1078-1439(19)30351.
    Abstract     Related articles   

  38. LIN YH, Hou CP, Juang HH, Chang PL, et al
    Association between Bladder Outlet Obstruction and Bladder Cancer in Patients with Aging Male.
    J Clin Med. 2019;8.
    Abstract     Related articles   

  39. YANG D, Ma Y, Zhao P, Ma J, et al
    Systematic screening of protein-coding gene expression identified HMMR as a potential independent indicator of unfavorable survival in patients with papillary muscle-invasive bladder cancer.
    Biomed Pharmacother. 2019;120:109433.
    Abstract     Related articles   

  40. LIU F, Liu A, Lu X, Zhang Z, et al
    Dysbiosis signatures of the microbial profile in tissue from bladder cancer.
    Cancer Med. 2019 Sep 30. doi: 10.1002/cam4.2419.
    Abstract     Related articles   

  41. CHI Q, Wang ZY, Li HY, Song DB, et al
    Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.
    Chin Med J (Engl). 2019 Sep 17. doi: 10.1097/CM9.0000000000000455.
    Abstract     Related articles   

  42. SHI J, Zhang P, Liu L, Min X, et al
    Weighted gene coexpression network analysis identifies a new biomarker of CENPF for prediction disease prognosis and progression in nonmuscle invasive bladder cancer.
    Mol Genet Genomic Med. 2019 Sep 30:e982. doi: 10.1002.
    Abstract     Related articles   

  43. LIU X, Zhang X, Bi J, Li Z, et al
    Caspase recruitment domain family member 10 regulates carbamoyl phosphate synthase 1 and promotes cancer growth in bladder cancer cells.
    J Cell Mol Med. 2019 Sep 29. doi: 10.1111/jcmm.14683.
    Abstract     Related articles   

  44. TETTEH-QUARCOO PB, Akuetteh BK, Owusu IA, Quayson SE, et al
    Cytological and Wet Mount Microscopic Observations Made in Urine of Schistosoma haematobium-Infected Children: Hint of the Implication in Bladder Cancer.
    Can J Infect Dis Med Microbiol. 2019;2019:7912186.
    Abstract     Related articles   

  45. WU X, Xu Q, Chen P, Yu C, et al
    Effect of SMYD3 on biological behavior and H3K4 methylation in bladder cancer.
    Cancer Manag Res. 2019;11:8125-8133.
    Abstract     Related articles   

  46. DI MASO M, Turati F, Bosetti C, Montella M, et al
    Food consumption, meat cooking methods and diet diversity and the risk of bladder cancer.
    Cancer Epidemiol. 2019;63:101595.
    Abstract     Related articles   

  47. YANG X, Wang P
    MiR-188-5p and MiR-141-3p influence prognosis of bladder cancer and promote bladder cancer synergistically.
    Pathol Res Pract. 2019 Aug 17:152598. doi: 10.1016/j.prp.2019.152598.
    Abstract     Related articles   

  48. GRIMBERG DC, Shah A, Inman BA
    Overview of Taris GemRIS, a Novel Drug Delivery System for Bladder Cancer.
    Eur Urol Focus. 2019 Sep 24. pii: S2405-4569(19)30282.
    Abstract     Related articles   

    [The impact of using intraoperative photodynamic diagnosis on the prognosis of bladder cancer].
    Aktuelle Urol. 2019 Sep 26. doi: 10.1055/a-1007-8497.
    Abstract     Related articles   

  50. YANG L, Li YL, Li XQ, Zhang Z, et al
    Corrigendum to "High Apelin Level Indicates a Poor Prognostic Factor in Muscle-Invasive Bladder Cancer".
    Dis Markers. 2019;2019:5974238.
    Abstract     Related articles   

  51. APOLO AB
    Determining superior first-line therapy in metastatic bladder cancer.
    Nat Rev Urol. 2019 Sep 26. pii: 10.1038/s41585-019-0245.
    Abstract     Related articles   

  52. WYLIE H, Cahill F, Santaolalla A, Moss CL, et al
    Graham Roberts Study protocol: first 'trials within cohort study' for bladder cancer.
    BMJ Open. 2019;9:e029468.
    Abstract     Related articles   

  53. ENIKEEV DV, Alyaev YG, Rapoport LM, Taratkin MS, et al
    [Multidisciplinary approach in urology. Laser technologies: faster, simpler, more efficient].
    Urologiia. 2019;.
    Abstract     Related articles   

  54. LI G, Sun L, Mu Z, Liu S, et al
    MicroRNA-1298-5p inhibits cell proliferation and invasion of bladder cancer via downregulating connexin 43.
    Biochem Cell Biol. 2019 Oct 10. doi: 10.1139/bcb-2019-0137.
    Abstract     Related articles   

  55. BURGESS EF, Livasy C, Trufan S, Hartman A, et al
    High aurora kinase expression identifies patients with muscle-invasive bladder cancer who have poor survival after neoadjuvant chemotherapy.
    Urol Oncol. 2019 Oct 6. pii: S1078-1439(19)30360.
    Abstract     Related articles   

  56. PAPADIMITRIOU MA, Avgeris M, Levis PK, Tokas T, et al
    DeltaNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression.
    J Cancer Res Clin Oncol. 2019 Oct 8. pii: 10.1007/s00432-019-03028.
    Abstract     Related articles   

  57. LIU A, Xue Y, Liu F, Tan H, et al
    Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomy.
    Cancer Biomark. 2019 Sep 27. pii: CBM182143. doi: 10.3233/CBM-182143.
    Abstract     Related articles   

  58. CHEN C, Luo Y, He W, Zhao Y, et al
    Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer.
    J Clin Invest. 2019 Oct 8. pii: 130892. doi: 10.1172/JCI130892.
    Abstract     Related articles   

  59. ZHOU Q, Chen S, Lu M, Luo Y, et al
    EFEMP2 suppresses epithelial-mesenchymal transition via Wnt/beta-catenin signaling pathway in human bladder cancer.
    Int J Biol Sci. 2019;15:2139-2155.
    Abstract     Related articles   

  60. PARK C, Cha HJ, Choi EO, Lee H, et al
    Isorhamnetin Induces Cell Cycle Arrest and Apoptosis Via Reactive Oxygen Species-Mediated AMP-Activated Protein Kinase Signaling Pathway Activation in Human Bladder Cancer Cells.
    Cancers (Basel). 2019;11.
    Abstract     Related articles   

  61. CHESTNUT C, Smelser W, Dum T, Bechtel M, et al
    Glycemic impact of a diet and lifestyle intervention on diabetics and prediabetics during treatment for non-muscle invasive bladder cancer.
    Nutr Cancer. 2019 Oct 7:1-6. doi: 10.1080/01635581.2019.1672761.
    Abstract     Related articles   

  62. GRONOSTAJ K, Czech AK, Fronczek J, Drobniak A, et al
    The Prognostic Value of Tumor Regression Grades Combined With TNM Classification in Patients With Muscle-Invasive Bladder Cancer Who Underwent Neoadjuvant Chemotherapy Followed by Radical Cystectomy.
    Clin Genitourin Cancer. 2019 Sep 12. pii: S1558-7673(19)30272.
    Abstract     Related articles   

  63. TSAI TF, Chen PC, Lin YC, Chou KY, et al
    Benzyl isothiocyanate promotes miR-99a expression through ERK/AP-1-dependent pathway in bladder cancer cells.
    Environ Toxicol. 2019 Oct 6. doi: 10.1002/tox.22841.
    Abstract     Related articles   

  64. ROUDAFSHANI Z, Jazayeri MH, Mahmoudi AR, Nedaeinia R, et al
    Evaluation of the frequency of CD5(+) B cells as natural immunoglobulin M producers and circulating soluble CD5 in patients with bladder cancer.
    Mol Biol Rep. 2019 Oct 5. pii: 10.1007/s11033-019-05087.
    Abstract     Related articles   

  65. CARRION A, Huguet J, Ribal MJ, Dominguez A, et al
    Comparison of standard vs. palliative management for bladder cancer in patients older than 85 years: multicenter study of 317 de novo tumors.
    Urol Oncol. 2019 Oct 2. pii: S1078-1439(19)30358.
    Abstract     Related articles   

  66. GENITSCH V, Kollar A, Vandekerkhove G, Blarer J, et al
    Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
    Urol Oncol. 2019 Oct 1. pii: S1078-1439(19)30376.
    Abstract     Related articles   

  67. KASANGA TK, Ntanga DI, Musapoudi EM, Kapessa ND, et al
    [Recurrent invasive bladder urothelial carcinoma treated by cystectomy with substitutive ileal enterocystoplasty: case report].
    Pan Afr Med J. 2019;33:184.
    Abstract     Related articles   

  68. BRIENS A, Castelli J, Barateau A, Jaksic N, et al
    [Adaptive radiotherapy: Strategies and benefits depending on tumor localization].
    Cancer Radiother. 2019;23.
    Abstract     Related articles   

  69. OUEDRAOGO S, Traore MT, Kambire JL, Ouedraogo S, et al
    [Primary urological cancers in a context of limited resources: Epidemiology and treatment].
    Bull Cancer. 2019;106:868-874.
    Abstract     Related articles   

  70. BAHRAMI S, Kazemi B, Zali H, Black PC, et al
    Discovering therapeutic protein targets for muscle invasive bladder cancer by proteomic data analysis.
    Curr Mol Pharmacol. 2019 Oct 16. pii: CMP-EPUB-101531.
    Abstract     Related articles   

  71. WANG F, Cao M, Fan M, Wu H, et al
    AMPK-mTOR-ULK1 axis activation-dependent autophagy promotes hydroxycamptothecin-induced apoptosis in human bladder cancer cells.
    J Cell Physiol. 2019 Oct 16. doi: 10.1002/jcp.29307.
    Abstract     Related articles   

  72. YUAN S, Luan X, Han G, Guo K, et al
    LINC01638 lncRNA mediates the postoperative distant recurrence of bladder cancer by upregulating ROCK2.
    Oncol Lett. 2019;18:5392-5398.
    Abstract     Related articles   

  73. GRANT CM, Amdur R, Whalen MJ
    Trends in the use of neoadjuvant chemotherapy for bladder cancer with nonurothelial variant histology: An analysis of the National Cancer Database.
    Indian J Urol. 2019;35:291-298.
    Abstract     Related articles   

  74. DE GOEIJ L, Westhoff E, Witjes JA, Aben KK, et al
    The UroLife study: protocol for a Dutch prospective cohort on lifestyle habits in relation to non-muscle-invasive bladder cancer prognosis and health-related quality of life.
    BMJ Open. 2019;9:e030396.
    Abstract     Related articles   

  75. DE JONG JJ, Liu Y, Robertson AG, Seiler R, et al
    Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis.
    Genome Med. 2019;11:60.
    Abstract     Related articles   

  76. WANG B, Wang Z, Zhang T, Yang G, et al
    Overexpression of thymosin beta10 correlates with disease progression and poor prognosis in bladder cancer.
    Exp Ther Med. 2019;18:3759-3766.
    Abstract     Related articles   

  77. ZHU L, Sun J, Wang L, Li Z, et al
    Prognostic and Clinicopathological Significance of PD-L1 in Patients With Bladder Cancer: A Meta-Analysis.
    Front Pharmacol. 2019;10:962.
    Abstract     Related articles   

  78. WANG TW, Yuan H, Diao WL, Yang R, et al
    Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence.
    BMC Urol. 2019;19:90.
    Abstract     Related articles   

  79. FANG C, Xu L, He W, Dai J, et al
    Long noncoding RNA DLX6-AS1 promotes cell growth and invasiveness in bladder cancer via modulating the miR-223-HSP90B1 axis.
    Cell Cycle. 2019 Oct 15:1-12. doi: 10.1080/15384101.2019.1673633.
    Abstract     Related articles   

  80. BORKOWSKA EM, Konecki T, Pietrusinski M, Borowiec M, et al
    MicroRNAs Which Can Prognosticate Aggressiveness of Bladder Cancer.
    Cancers (Basel). 2019;11.
    Abstract     Related articles   

  81. NITTA M, Kuroda S, Nagao K, Higure T, et al
    Effect of neoadjuvant chemotherapy in patients undergoing radical cystectomy for muscle-invasive bladder cancer: a retrospective, multi-institutional study.
    Jpn J Clin Oncol. 2019 Oct 15. pii: 5587304. doi: 10.1093.
    Abstract     Related articles   

  82. DING ZS, He YH, Deng YS, Peng PX, et al
    MicroRNA-34a inhibits bladder cancer cell migration and invasion, and upregulates PTEN expression.
    Oncol Lett. 2019;18:5549-5554.
    Abstract     Related articles   

  83. YOSHIDA T, Sopko NA, Kates M, Liu X, et al
    Impact of spheroid culture on molecular and functional characteristics of bladder cancer cell lines.
    Oncol Lett. 2019;18:4923-4929.
    Abstract     Related articles   

  84. YANG Y, Zhang F, Huang H, Xie Z, et al
    Long noncoding RNA LINC00319 regulates ROMO1 expression and promotes bladder cancer progression via miR-4492/ROMO1 axis.
    J Cell Physiol. 2019 Oct 14. doi: 10.1002/jcp.29271.
    Abstract     Related articles   

  85. CHEREMISIN D, Andropova P, Gavrilov P
    Reply to: BCG infection following immunotherapy for bladder cancer.
    QJM. 2019 Oct 14. pii: 5586893. doi: 10.1093.
    Abstract     Related articles   

  86. MOSINA N, Kayukov I
    Renal tuberculosis following BCG therapy for bladder cancer.
    QJM. 2019 Oct 14. pii: 5586891. doi: 10.1093.
    Abstract     Related articles   

  87. KOUBA E, Lopez-Beltran A, Montironi R, Massari F, et al
    Liquid biopsy in the clinical management of bladder cancer: current status and future developments.
    Expert Rev Mol Diagn. 2019 Oct 17:1-10. doi: 10.1080/14737159.2019.1680284.
    Abstract     Related articles   

  88. SZARVAS T, Olah C, Riesz P, Geczi L, et al
    [Molecular subtype classification of urothelial bladder cancer and its clinical relevance].
    Orv Hetil. 2019;160:1647-1654.
    Abstract     Related articles   

  89. LIU S, Chen Q, Wang Y
    MiR-125b-5p suppresses the bladder cancer progression via targeting HK2 and suppressing PI3K/AKT pathway.
    Hum Cell. 2019 Oct 11. pii: 10.1007/s13577-019-00285.
    Abstract     Related articles   

  90. MA W, Ma J, Lei T, Zhao M, et al
    Targeting immunotherapy for bladder cancer by using anti-CD3 x CD155 bispecific antibody.
    J Cancer. 2019;10:5153-5161.
    Abstract     Related articles   

  91. ZHOU K, Yang J, Li X, Chen W, et al
    Long non-coding RNA XIST promotes cell proliferation and migration through targeting miR-133a in bladder cancer.
    Exp Ther Med. 2019;18:3475-3483.
    Abstract     Related articles   

  92. TANG F, He Z, Lu Z, Wu W, et al
    Application of nomograms in the prediction of overall survival and cancer-specific survival in patients with T1 high-grade bladder cancer.
    Exp Ther Med. 2019;18:3405-3414.
    Abstract     Related articles   

  93. VESKIMAE E, Espinos EL, Bruins HM, Yuan Y, et al
    What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology
    Eur Urol Oncol. 2019 Oct 7. pii: S2588-9311(19)30144.
    Abstract     Related articles   

  94. MARTIN KA, Hum NR, Sebastian A, He W, et al
    Methionine Adenosyltransferase 1a (MAT1A) Enhances Cell Survival During Chemotherapy Treatment and is Associated with Drug Resistance in Bladder Cancer PDX Mice.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  95. UCPINAR B, Erbin A, Ayranci A, Caglar U, et al
    Prediction of recurrence in non-muscle invasive bladder cancer patients. Do patient characteristics matter?
    J BUON. 2019;24:1659-1665.
    Abstract     Related articles   

  96. CHEN L, Hu W, Li G, Guo Y, et al
    Efficacy of bladder perfusion of alternating hydroxycamptothecin and gemcitabine combined with low-dose tuberculin in the treatment of non-muscle invasive bladder cancer after TURBT.
    J BUON. 2019;24:1652-1658.
    Abstract     Related articles   

  97. WAHLIN S, Nodin B, Leandersson K, Boman K, et al
    Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer: a comparative study of transurethral resection and cystectomy specimens.
    Oncoimmunology. 2019;8:e1644108.
    Abstract     Related articles   

  98. WOODFORD MR, Hughes M, Sager RA, Backe SJ, et al
    Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity.
    Oncotarget. 2019;10:5824-5834.
    Abstract     Related articles   

  99. SHI H, Li J, Li K, Yang X, et al
    Minimally invasive versus open radical cystectomy for bladder cancer: A systematic review and meta-analysis.
    J Int Med Res. 2019;47:4604-4618.
    Abstract     Related articles   

  100. ZHANG N, Wang X, Wang C, Chen S, et al
    Diagnostic Accuracy of Multi-Parametric Magnetic Resonance Imaging for Tumor Staging of Bladder Cancer: Meta-Analysis.
    Front Oncol. 2019;9:981.
    Abstract     Related articles   

  101. ALDOGHACHI AF, Baharudin A, Ahmad U, Chan SC, et al
    Evaluation of CERS2 Gene as a Potential Biomarker for Bladder Cancer.
    Dis Markers. 2019;2019:3875147.
    Abstract     Related articles   

  102. SATO G, Yoshida T, Yanishi M, Saito R, et al
    Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Clin Genitourin Cancer. 2019 Sep 27. pii: S1558-7673(19)30286.
    Abstract     Related articles   

  103. SIDDIQUI Z, Srivastava AN, Sankhwar SN, Zaidi N, et al
    Oct-4: a prognostic biomarker of urinary bladder cancer in North India.
    Ther Adv Urol. 2019;11:1756287219875576.
    Abstract     Related articles   

  104. WU ZS, Ding W, Cai J, Bashir G, et al
    Communication Of Cancer Cells And Lymphatic Vessels In Cancer: Focus On Bladder Cancer.
    Onco Targets Ther. 2019;12:8161-8177.
    Abstract     Related articles   

  105. WANG RJ, Liu W, Mu XY, Yao ZX, et al
    Preoperative CD4(+)CD25(+)/CD4(+) and tumor diameter predict prognosis in male patients with bladder cancer.
    Biomark Med. 2019;13:1387-1397.
    Abstract     Related articles   

  106. LI WM, Wu WJ
    Transgelin in bladder cancer: A potential biomarker and therapeutic target.
    EBioMedicine. 2019 Oct 17. pii: S2352-3964(19)30609.
    Abstract     Related articles   

  107. FERNANDEZ MI, Valdebenito P, Delgado I, Segebre J, et al
    Impact of arsenic exposure on clinicopathological characteristics of bladder cancer: A comparative study between patients from an arsenic-exposed region and nonexposed reference sites.
    Urol Oncol. 2019 Oct 17. pii: S1078-1439(19)30364.
    Abstract     Related articles   

  108. FUKUOKAYA W, Kimura T, Miki J, Kimura S, et al
    Effectiveness of Intravesical Doxorubicin Immediately Following Resection of Primary Non-muscle-invasive Bladder Cancer: A Propensity Score-matched Analysis.
    Clin Genitourin Cancer. 2019 Sep 27. pii: S1558-7673(19)30274.
    Abstract     Related articles   

  109. VOSKUILEN CS, Bosschieter J, van Werkhoven E, Hendricksen K, et al
    Long-term survival and complications following bladder-preserving brachytherapy in patients with cT1-T2 bladder cancer.
    Radiother Oncol. 2019 Oct 17. pii: S0167-8140(19)33115.
    Abstract     Related articles   

  110. FARAJ K, Chang YH, Rose KM, Habermann EB, et al
    Single-dose perioperative mitomycin-C versus thiotepa for low-grade noninvasive bladder cancer.
    Can J Urol. 2019;26:9922-9930.
    Abstract     Related articles   

  111. CHEN C, Huang H, Zhao Y, Liu H, et al
    Diagnostic performance of image technique based transurethral resection for non-muscle invasive bladder cancer: systematic review and diagnostic meta-analysis.
    BMJ Open. 2019;9:e028173.
    Abstract     Related articles   

  112. NGUYEN HT, Shah ZK, Mortazavi A, Pohar KS, et al
    Periodically rotated overlapping parallel lines with enhanced reconstruction acquisition to improve motion-induced artifacts in bladder cancer imaging: Initial findings.
    Medicine (Baltimore). 2019;98:e17075.
    Abstract     Related articles   

  113. FUJIMI A, Nagamachi Y, Yamauchi N, Tamura F, et al
    Gastrointestinal Stromal Tumor in a Patient with Neurofibromatosis Type 1 That Was Successfully Treated with Regorafenib.
    Intern Med. 2019;58:1865-1870.
    Abstract     Related articles   

  114. YANG G, Liu M, Liu Q, Duan X, et al
    Granulocytic myeloid-derived suppressor cells correlate with outcomes undergoing neoadjuvant chemotherapy for bladder cancer.
    Urol Oncol. 2019 Oct 28. pii: S1078-1439(18)30235.
    Abstract     Related articles   

  115. FURUYA H, Pagano I, Chee K, Kobayashi T, et al
    Comparison of Commercial ELISA Kits, a Prototype Multiplex Electrochemoluminescent Assay, and a Multiplex Bead-Based Immunoassay for Detecting a Urine-Based Bladder-Cancer-Associated Diagnostic Signature.
    Diagnostics (Basel). 2019;9.
    Abstract     Related articles   

  116. DE KEUKELEIRE S, De Maeseneer D, Jacobs C, Rottey S, et al
    Targeting FGFR in bladder cancer: ready for clinical practice?
    Acta Clin Belg. 2019 Oct 31:1-8. doi: 10.1080/17843286.2019.1685738.
    Abstract     Related articles   

  117. APOLO AB, Milowsky MI, Kim L, Inman BA, et al
    Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer.
    JAMA Oncol. 2019 Oct 31:1-9. doi: 10.1001/jamaoncol.2019.4114.
    Abstract     Related articles   

  118. WANG Y, Shen Y, Hu X, Li Z, et al
    Application of R2* and Apparent Diffusion Coefficient in Estimating Tumor Grade and T Category of Bladder Cancer.
    AJR Am J Roentgenol. 2019 Oct 31:1-7. doi: 10.2214/AJR.19.21668.
    Abstract     Related articles   

  119. RUSSELL B, Liedberg F, Khan MS, Nair R, et al
    A Systematic Review and Meta-analysis of Delay in Radical Cystectomy and the Effect on Survival in Bladder Cancer Patients.
    Eur Urol Oncol. 2019 Oct 23. pii: S2588-9311(19)30151.
    Abstract     Related articles   

  120. BRAICU C, Buiga R, Cojocneanu R, Buse M, et al
    Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression.
    J Exp Clin Cancer Res. 2019;38:433.
    Abstract     Related articles   

  121. ALJABERY F, Liedberg F, Haggstrom C, Strock V, et al
    Management and outcome of muscle-invasive bladder cancer with clinical lymph node metastases. A nationwide population-based study in the bladder cancer data base Sweden (BladderBaSe).
    Scand J Urol. 2019 Oct 30:1-7. doi: 10.1080/21681805.2019.1681504.
    Abstract     Related articles   

  122. WANG R, Yan Y, Liu S, Yao X, et al
    Comparison of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Bladder Cancer Patients Undergoing Radical Cystectomy.
    Biomed Res Int. 2019;2019:3628384.
    Abstract     Related articles   

  123. TEY J, Soon YY, Cheo T, Ooi KH, et al
    Efficacy of Palliative Bladder Radiotherapy for Hematuria in Advanced Bladder Cancer Using Contemporary Radiotherapy Techniques.
    In Vivo. 2019;33:2161-2167.
    Abstract     Related articles   

  124. LIU YC, Lin KH, Hsieh JH, Chung JG, et al
    Hyperforin Induces Apoptosis Through Extrinsic/Intrinsic Pathways and Inhibits NF-kB-modulated Survival and Invasion Potential in Bladder Cancer.
    In Vivo. 2019;33:1865-1877.
    Abstract     Related articles   

  125. SUN N, Liang Y, Chen Y, Wang L, et al
    Glutamine affects T24 bladder cancer cell proliferation by activating STAT3 through ROS and glutaminolysis.
    Int J Mol Med. 2019 Oct 25. doi: 10.3892/ijmm.2019.4385.
    Abstract     Related articles   

  126. CAO R, Yuan L, Ma B, Wang G, et al
    An EMT-related gene signature for the prognosis of human bladder cancer.
    J Cell Mol Med. 2019 Oct 28. doi: 10.1111/jcmm.14767.
    Abstract     Related articles   

  127. JAIN H, Gada K, Zaidi S, Asiago-Reddy E, et al
    Mycobacterium bovis epidural abscess following Bacillus Calmette-Guerin therapy for bladder cancer.
    Proc (Bayl Univ Med Cent). 2019;32:577-578.
    Abstract     Related articles   

  128. DONG F, Chen L, Wang R, Yang W, et al
    4-nitrophenol exposure in T24 human bladder cancer cells promotes proliferation, motilities and epithelial-to-mesenchymal transition.
    Environ Mol Mutagen. 2019 Oct 26. doi: 10.1002/em.22345.
    Abstract     Related articles   

  129. QUERIDO S, Fernandes I, Weigert A, Casimiro S, et al
    High-grade urothelial carcinoma in a kidney transplant recipient after JC virus nephropathy: the first evidence of JC virus as a potential oncovirus in bladder cancer.
    Am J Transplant. 2019 Oct 25. doi: 10.1111/ajt.15663.
    Abstract     Related articles   

  130. CHRISTOPH F, Herrmann F, Werthemann P, Janik T, et al
    Ureteroenteric strictures: a single center experience comparing Bricker versus Wallace ureteroileal anastomosis in patients after urinary diversion for bladder cancer.
    BMC Urol. 2019;19:100.
    Abstract     Related articles   

  131. KOUBA E, Cheng L
    Clinical utility versus futility: a tipping point for liquid biopsies in bladder cancer.
    Future Oncol. 2019 Oct 25. doi: 10.2217/fon-2019-0522.
    Abstract     Related articles   

  132. LIU P, Li X, Cui Y, Chen J, et al
    LncRNA-MALAT1 mediates cisplatin resistance via miR-101-3p/VEGF-C pathway in bladder cancer.
    Acta Biochim Biophys Sin (Shanghai). 2019 Oct 23. pii: 5603543.
    Abstract     Related articles   

  133. PENG M, Deng J, Zhou S, Xiao D, et al
    Dual Inhibition of Pirarubicin-Induced AKT and ERK Activations by Phenformin Sensitively Suppresses Bladder Cancer Growth.
    Front Pharmacol. 2019;10:1159.
    Abstract     Related articles   

  134. YAN D, Dong W, He Q, Yang M, et al
    Circular RNA circPICALM sponges miR-1265 to inhibit bladder cancer metastasis and influence FAK phosphorylation.
    EBioMedicine. 2019 Oct 21. pii: S2352-3964(19)30596.
    Abstract     Related articles   

  135. KISLYAKOV DA, Severgina LO, Tsarichenko DG, Rapoport LM, et al
    [Novel approaches for transurethral en-bloc resection of large bladder tumors].
    Urologiia. 2019;:105-111.
    Abstract     Related articles   

  136. DARENKOV SP, Pinchuk IS, Proskokov AA, Trofimchuk AD, et al
    [Radical cystectomy: therapeutic aspects of preoperative and early postoperative management].
    Urologiia. 2019;:44-50.
    Abstract     Related articles   

  137. HOLMANG S, Hedelin H, Malmstrom PU

    Lakartidningen. 2019;116.
    Abstract     Related articles   

  138. ZHANG B, Fu Z, Liu L, Qiao B, et al
    Non-functional paraganglioma of urinary bladder managed by transurethral resection.
    Int Braz J Urol. 2019;45:910-915.
    Abstract     Related articles   

  139. ZHANG M, Chen Y, Cong X, Zhao X, et al
    Utility of intravoxel incoherent motion MRI derived parameters for prediction of aggressiveness in urothelial bladder carcinoma.
    J Magn Reson Imaging. 2018 May 8. doi: 10.1002/jmri.26165.
    Abstract     Related articles   

  140. FERNANDEZ-CONEJO G, de la Pena E, Hernandez V, Castro A, et al
    Incidence and prognosis of clinically significant incidental prostate cancer after radical cystectomy for bladder cancer.
    Arch Esp Urol. 2019;72:915-920.
    Abstract     Related articles   

  141. ZHANG L, Wang CZ, Ma M, Shao GF, et al
    MiR-15 suppressed the progression of bladder cancer by targeting BMI1 oncogene via PI3K/AKT signaling pathway.
    Eur Rev Med Pharmacol Sci. 2019;23:8813-8822.
    Abstract     Related articles   

  142. ZHU QL, Zhan DM, Chong YK, Ding L, et al
    MiR-652-3p promotes bladder cancer migration and invasion by targeting KCNN3.
    Eur Rev Med Pharmacol Sci. 2019;23:8806-8812.
    Abstract     Related articles   

  143. XIONG M, Chen L, Zhou L, Ding Y, et al
    NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.
    Theranostics. 2019;9:7156-7167.
    Abstract     Related articles   

  144. MAZZONE E, Knipper S, Mistretta FA, Palumbo C, et al
    Trends and Social Barriers for Inpatient Palliative Care in Patients With Metastatic Bladder Cancer Receiving Critical Care Therapies.
    J Natl Compr Canc Netw. 2019;17:1344-1352.
    Abstract     Related articles   

  145. TAE JH, Pyun JH, Shim JS, Cho S, et al
    Oncological and functional outcomes of robot-assisted radical cystectomy in bladder cancer patients in a single tertiary center: Can these be preserved throughout the learning curve?
    Investig Clin Urol. 2019;60:463-471.
    Abstract     Related articles   

  146. ZHANG C, Chang X, Chen D, Yang F, et al
    Downregulation of HDGF inhibits the tumorigenesis of bladder cancer cells by inactivating the PI3K-AKT signaling pathway.
    Cancer Manag Res. 2019;11:7909-7923.
    Abstract     Related articles   

  147. DE NUNZIO C, Giannatempo P, Passalacqua R, Fiorini E, et al
    Epidemiology and unmet needs of bladder cancer in Italy: a critical review.
    Minerva Urol Nefrol. 2019 Nov 4. pii: S0393-2249.19.03498.
    Abstract     Related articles   

  148. YAO J, Zhang Z, Li S, Li B, et al
    Melittin inhibits proliferation, migration and invasion of bladder cancer cells by regulating key genes based on bioinformatics and experimental assays.
    J Cell Mol Med. 2019 Nov 5. doi: 10.1111/jcmm.14775.
    Abstract     Related articles   

  149. HURLE R, Casale P, Saita A, Colombo P, et al
    Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) proj
    World J Urol. 2019 Nov 5. pii: 10.1007/s00345-019-03002.
    Abstract     Related articles   

  150. ZHANG Y, Hong YK, Zhuang DW, He XJ, et al
    Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.
    Medicine (Baltimore). 2019;98:e17725.
    Abstract     Related articles   

  151. LI Z, Wei D, Zhu C, Zhang Q, et al
    Effect of a patient education and rehabilitation program on anxiety, depression and quality of life in muscle invasive bladder cancer patients treated with adjuvant chemotherapy.
    Medicine (Baltimore). 2019;98:e17437.
    Abstract     Related articles   

  152. ALLEN BC, Oto A, Akin O, Alexander LF, et al
    ACR Appropriateness Criteria(R) Post-Treatment Surveillance of Bladder Cancer.
    J Am Coll Radiol. 2019;16.
    Abstract     Related articles   

  153. YU H, Wu CL, Wang X, Ban Q, et al
    SP600125 enhances C-2-induced cell death by the switch from autophagy to apoptosis in bladder cancer cells.
    J Exp Clin Cancer Res. 2019;38:448.
    Abstract     Related articles   

  154. BOUBAKER NS, Gurtner A, Trabelsi N, Manni I, et al
    Evaluating prognostic utility of preoperative Neutrophil to Lymphocyte Ratio and hsa-let-7g/c up-regulation in patients with urinary bladder cancer.
    Cancer Biomark. 2019 Oct 25. pii: CBM190483. doi: 10.3233/CBM-190483.
    Abstract     Related articles   

  155. HWANG B, Shin SS, Song JH, Choi YH, et al
    Carnosine exerts antitumor activity against bladder cancers in vitro and in vivo via suppression of angiogenesis.
    J Nutr Biochem. 2019;74:108230.
    Abstract     Related articles   

  156. LIPUNOVA N, Wesselius A, Cheng KK, van Schooten FJ, et al
    External Replication of Urinary Bladder Cancer Prognostic Polymorphisms in the UK Biobank.
    Front Oncol. 2019;9:1082.
    Abstract     Related articles   

  157. WANG Y, Chen L, Ju L, Qian K, et al
    Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis.
    Front Oncol. 2019;9:1030.
    Abstract     Related articles   

  158. WENTLAND AL, Desser TS, Troxell ML, Kamaya A, et al
    Bladder cancer and its mimics: a sonographic pictorial review with CT/MR and histologic correlation.
    Abdom Radiol (NY). 2019 Nov 1. pii: 10.1007/s00261-019-02276.
    Abstract     Related articles   

  159. RICHTERS A, Aben KKH, Kiemeney LALM
    The global burden of urinary bladder cancer: an update.
    World J Urol. 2019 Nov 1. pii: 10.1007/s00345-019-02984.
    Abstract     Related articles   

  160. KAUSHIK D, Shi Z, Liss MA, Wang H, et al
    Screening logs from a pilot randomized controlled trial of radical cystectomy versus chemoradiation therapy for muscle-invasive bladder cancer.
    Urol Oncol. 2019 Oct 29. pii: S1078-1439(19)30359.
    Abstract     Related articles   

  161. BLACK AJ, Zargar H, Zargar-Shoshtari K, Fairey AS, et al
    The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy.
    Urol Oncol. 2019 Oct 29. pii: S1078-1439(19)30374.
    Abstract     Related articles   

  162. JIANG C, Zhao W, Qin M, Jin M, et al
    CD56-chimeric antigen receptor T-cell therapy for refractory/recurrent rhabdomyosarcoma: A 3.5-year follow-up case report.
    Medicine (Baltimore). 2019;98:e17572.
    Abstract     Related articles   

  163. TATEOKA J, Wada N, Tamaki G, Kikuchi D, et al
    [A Case of Adenocarcinoma of the Reconstructed Bladder 45 Years after Ileocystoplasty].
    Hinyokika Kiyo. 2019;65:305-308.
    Abstract     Related articles   

  164. CAI H, Yang X, Gao Y, Xu Z, et al
    Exosomal MicroRNA-9-3p Secreted from BMSCs Downregulates ESM1 to Suppress the Development of Bladder Cancer.
    Mol Ther Nucleic Acids. 2019;18:787-800.
    Abstract     Related articles   

  165. WAHAFU W, Liu S, Xu W, Wang M, et al
    The long-term efficacy of one-shot neoadjuvant intra-arterial chemotherapy combined with radical cystectomy versus radical cystectomy alone for bladder cancer: a propensity-score matching study.
    BMC Urol. 2019;19:117.
    Abstract     Related articles   

  166. KOCSMAR I, Pajor G, Gyongyosi B, Szekely E, et al
    Development and Initial Testing of a Modified UroVysion-Based Fluorescence In Situ Hybridization Score for Prediction of Progression in Bladder Cancer.
    Am J Clin Pathol. 2019 Nov 16. pii: 5626496. doi: 10.1093.
    Abstract     Related articles   

  167. BALBAY MD, Canda AE, Kiremit MC, Koseoglu E, et al
    Intracorporeal Studer pouch formation with Balbay's technique following robotic radical cystectomy for bladder cancer: Experience with 22 cases with oncologic and functional outcomes.
    J Endourol. 2019 Nov 15. doi: 10.1089/end.2019.0559.
    Abstract     Related articles   

  168. LIN GB, Zhang CM, Chen XY, Wang JW, et al
    Identification of circulating miRNAs as novel prognostic biomarkers for bladder cancer.
    Math Biosci Eng. 2019;17:834-844.
    Abstract     Related articles   

  169. RASSY E, Assi T, Kattan J
    Is there a role for maintenance therapy after platinum chemotherapy in bladder cancer in the era of immune therapy?
    Future Oncol. 2019 Nov 15. doi: 10.2217/fon-2019-0542.
    Abstract     Related articles   

  170. ZHU D, Li H
    Case Study: Landscape of Chimeric RNAs in Bladder Cancer.
    Methods Mol Biol. 2020;2079:233-241.
    Abstract     Related articles   

  171. TAO K, Liu S, Wang L, Qiu H, et al
    Targeted multifunctional nanomaterials with MRI, chemotherapy and photothermal therapy for the diagnosis and treatment of bladder cancer.
    Biomater Sci. 2019 Nov 14. doi: 10.1039/c9bm01377.
    Abstract     Related articles   

  172. KIM A, Kim MS, Ahn JH, Choi WS, et al
    Clinical significance of 5-alpha reductase inhibitor and androgen deprivation therapy in bladder cancer incidence, recurrence, and survival: a meta-analysis and systemic review.
    Aging Male. 2019 Nov 14:1-8. doi: 10.1080/13685538.2019.1646238.
    Abstract     Related articles   

  173. MEHROTRA S, Rowland M, Zhang H, Russell B, et al
    Scoping review protocol: is there a role for physical activity interventions in the treatment pathway of bladder cancer?
    BMJ Open. 2019;9:e033518.
    Abstract     Related articles   

  174. QI Y, Chang Y, Wang Z, Chen L, et al
    Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response.
    Cancer Immunol Immunother. 2019 Nov 12. pii: 10.1007/s00262-019-02429.
    Abstract     Related articles   

  175. CZECH AK, Gronostaj K, Frydrych J, Fronczek J, et al
    Identification of potential prognostic factors for absence of residual disease in the second resection of T1 bladder cancer.
    Cent European J Urol. 2019;72:252-257.
    Abstract     Related articles   

  176. STROMYER ML, Southerland MR, Satyal U, Sikder RK, et al
    Synthesis, characterization, and biological activity of a triphenylphosphonium-containing imidazolium salt against select bladder cancer cell lines.
    Eur J Med Chem. 2019 Oct 31:111832. doi: 10.1016/j.ejmech.2019.111832.
    Abstract     Related articles   

  177. SIDDIQUI Z, Srivastava AN, Sankhwar SN, Dalela D, et al
    Synergic effects of cancer stem cells markers, CD44 and embryonic stem cell transcription factor Nanog, on bladder cancer prognosis.
    Br J Biomed Sci. 2019 Nov 13. pii: 10.1080/09674845.2019.1692761.
    Abstract     Related articles   

  178. LIU MK, Ma T, Yu Y, Suo Y, et al
    MiR-1/GOLPH3/Foxo1 Signaling Pathway Regulates Proliferation of Bladder Cancer.
    Technol Cancer Res Treat. 2019;18:1533033819886897.
    Abstract     Related articles   

  179. ROSIELLO G, Knipper S, Palumbo C, Pecoraro A, et al
    Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion.
    Clin Genitourin Cancer. 2019 Oct 17. pii: S1558-7673(19)30316.
    Abstract     Related articles   

  180. LEO MC, McMullen CK, O'Keeffe-Rosetti M, Weinmann S, et al
    External validation of the EORTC and NCCN bladder cancer recurrence and progression risk calculators in a U.S. community-based health system.
    Urol Oncol. 2019 Nov 8. pii: S1078-1439(19)30404.
    Abstract     Related articles   

  181. MOTTERLE G, Andrews JR, Morlacco A, Karnes RJ, et al
    Predicting Response to Neoadjuvant Chemotherapy in Bladder Cancer.
    Eur Urol Focus. 2019 Nov 7. pii: S2405-4569(19)30338.
    Abstract     Related articles   

  182. LI W, Li Y, Ma W, Zhou J, et al
    Long noncoding RNA AC114812.8 promotes the progression of bladder cancer through miR-371b-5p/FUT4 axis.
    Biomed Pharmacother. 2019;121:109605.
    Abstract     Related articles   

  183. REIS H, Szarvas T
    [Predictive biomarkers in bladder cancer].
    Pathologe. 2019 Nov 8. pii: 10.1007/s00292-019-00688.
    Abstract     Related articles   

  184. SIM WJ, Iyengar PV, Lama D, Lui SKL, et al
    Author Correction: c-Met activation leads to the establishment of a TGFbeta-receptor regulatory network in bladder cancer progression.
    Nat Commun. 2019;10:5148.
    Abstract     Related articles   

  185. MORII Y, Osawa T, Suzuki T, Shinohara N, et al
    Cost comparison between open radical cystectomy, laparoscopic radical cystectomy, and robot-assisted radical cystectomy for patients with bladder cancer: a systematic review of segmental costs.
    BMC Urol. 2019;19:110.
    Abstract     Related articles   

  186. NGUYEN EK, Yu H, Pond G, Shayegan B, et al
    Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer.
    Can Urol Assoc J. 2019 Nov 5. pii: cuaj.5945. doi: 10.5489/cuaj.5945.
    Abstract     Related articles   

  187. ZHANG W, Wang R, Ma W, Wu Y, et al
    Systemic immune-inflammation index predicts prognosis of bladder cancer patients after radical cystectomy.
    Ann Transl Med. 2019;7:431.
    Abstract     Related articles   

  188. WANG QH, Ji JL, Li H, He PL, et al
    [Preoperative Lymphocyte-to-monocyte Ratio Predicts Prognosis in Patients with Stage T1 Non-muscle Invasive Bladder Cancer].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019;41:622-629.
    Abstract     Related articles   

  189. ZHANG Y, Wang Y, Song B, Li H, et al
    Patients' self-report anxiety, depression and quality of life and their predictive factors in muscle invasive bladder cancer patients receiving adjuvant chemotherapy.
    Psychol Health Med. 2019 Nov 8:1-11. doi: 10.1080/13548506.2019.1687912.
    Abstract     Related articles   

  190. TAN S, Kang Y, Li H, Zheng L, et al
    [Early complications after robot-assisted laparoscopic radical cystectomy and their risk factors].
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019;44:1003-1008.
    Abstract     Related articles   

  191. TOKURA T, Watanabe N, Morita T
    [A Case of Urachal Cancer at the Inserted Site of Cystostomy after 23 Years].
    Gan To Kagaku Ryoho. 2019;46:1656-1658.
    Abstract     Related articles   

  192. RAMIREZ BACKHAUS M, Calatrava-Fons A, Gomez-Ferrer A, Collado-Serra A, et al
    [ICG lymphography and fluorescence in pelvic lymphadenectomy for bladder and prostate cancer.]
    Arch Esp Urol. 2019;72:831-841.
    Abstract     Related articles   

  193. LUZZAGO S, Palumbo C, Rosiello G, Pecoraro A, et al
    The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder.
    J Surg Oncol. 2019;120:1266-1275.
    Abstract     Related articles   

  194. ANAND V, Khandelwal M, Appunni S, Gupta N, et al
    CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt/ERK/STAT3 pathways: novel therapeutic approach.
    J Cancer Res Clin Oncol. 2019;145:2649-2661.
    Abstract     Related articles   

  195. YOON HY, Chang IH, Goo YT, Kim CH, et al
    Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel.
    Int J Nanomedicine. 2019;14:6249-6268.
    Abstract     Related articles   

  196. BILLGER M, Kirk J, Chang J, Bedard A, et al
    Response to letter from Dr Oliviera in relation to our publication: A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin.
    Regul Toxicol Pharmacol. 2019;106:347-348.
    Abstract     Related articles   

  197. OLIVEIRA PA, Seixas F
    Re: A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin.
    Regul Toxicol Pharmacol. 2019;106:346.
    Abstract     Related articles   

  198. MEUNIER ME, Neuzillet Y, Raynaud JP, Radulescu C, et al
    Sex steroids in serum and prostatic tissue of human cancerous prostate (STERKPROSER trial).
    Prostate. 2019;79:272-280.
    Abstract     Related articles   

  199. ZALESKI M, Gogoj A, Walter V, Raman JD, et al
    Mitotic activity in noninvasive papillary urothelial carcinoma: its value in predicting tumor recurrence and comparison with the contemporary 2-tier grading system.
    Hum Pathol. 2019;84:275-282.
    Abstract     Related articles   

  200. BARRESI V, Nunnari CM, Lionti S
    Immunohistochemical stains to detect residual tumor in cystectomy specimens taken shortly after transurethral resection of bladder tumors.
    Ann Diagn Pathol. 2019;40:176-179.
    Abstract     Related articles   

  201. LI M, Liu Y, Liu J, Li W, et al
    Circ_0006332 promotes growth and progression of bladder cancer by modulating MYBL2 expression via miR-143.
    Aging (Albany NY). 2019;11.
    Abstract     Related articles   

  202. LARSEN ES, Joensen UN, Poulsen AM, Goletti D, et al
    Bacillus Calmette-Guerin immunotherapy for bladder cancer: A review of immunological aspects, clinical effects and BCG infections.
    APMIS. 2019 Nov 22. doi: 10.1111/apm.13011.
    Abstract     Related articles   

  203. BASU A, Sadeghi S
    Neoadjuvant Therapies for Bladder Cancer in Cisplatin-ineligible Patients: What Options Do We Have?
    Eur Urol Focus. 2019 Nov 18. pii: S2405-4569(19)30339.
    Abstract     Related articles   

  204. YAN L, Wang P, Fang W, Liang C, et al
    Cancer-associated fibroblasts-derived exosomes-mediated transfer of LINC00355 regulates bladder cancer cell proliferation and invasion.
    Cell Biochem Funct. 2019 Nov 21. doi: 10.1002/cbf.3462.
    Abstract     Related articles   

  205. ZHANG WY, Liu QH, Wang TJ, Zhao J, et al
    CircZFR serves as a prognostic marker to promote bladder cancer progression by regulating miR-377/ZEB2 signaling.
    Biosci Rep. 2019 Nov 20. pii: 221189. doi: 10.1042/BSR20192779.
    Abstract     Related articles   

  206. WASEDA Y, Kobayashi S, Kanda E, Yokoyama M, et al
    Impact of Bladder Neck Involvement on Recurrence in Patients With Non-muscle-invasive Bladder Cancer: An Analysis Based on a Time-dependent Model.
    Clin Genitourin Cancer. 2019 Oct 16. pii: S1558-7673(19)30309.
    Abstract     Related articles   

  207. AL-AHMADIE H, Netto GJ
    Updates on the Genomics of Bladder Cancer and Novel Molecular Taxonomy.
    Adv Anat Pathol. 2019 Nov 14. doi: 10.1097/PAP.0000000000000252.
    Abstract     Related articles   

  208. HECHLER V, Rink M, Beyersdorff D, Beer M, et al
    [The role of the vesical imaging-reporting and data system (VI-RADS) for bladder cancer diagnostics-status quo].
    Urologe A. 2019 Nov 18. pii: 10.1007/s00120-019-01061.
    Abstract     Related articles   

  209. HORWICH A, Babjuk M, Bellmunt J, Bruins HM, et al
    EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committeesdagger.
    Ann Oncol. 2019 Nov 19. pii: 5629133. doi: 10.1093.
    Abstract     Related articles   

  210. PAN S, Zhan Y, Chen X, Wu B, et al
    Bladder Cancer Exhibiting High Immune Infiltration Shows the Lowest Response Rate to Immune Checkpoint Inhibitors.
    Front Oncol. 2019;9:1101.
    Abstract     Related articles   

  211. CHEN S, Zhang N, Shao J, Wang T, et al
    A novel gene signature combination improves the prediction of overall survival in urinary bladder cancer.
    J Cancer. 2019;10:5744-5753.
    Abstract     Related articles   

  212. SONG BN, Kim SK, Mun JY, Choi YD, et al
    Identification of an immunotherapy-responsive molecular subtype of bladder cancer.
    EBioMedicine. 2019 Nov 15. pii: S2352-3964(19)30733.
    Abstract     Related articles   

  213. DENG LH, Xu FH, Zeng T, Xu XD, et al
    [Expression and Clinical Significance of Late Endosomal/Lysosomal Adaptor,Mitogen-activated Protein Kinase and Mammalian Target of Rapamycin Activator 3 in Bladder Carcinoma].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019;41:601-608.
    Abstract     Related articles   

  214. NOFUJI S, Kato R, Sakai Y, Konishi Y, et al
    [A Case of paraganglioma of Urinary Bladder].
    Hinyokika Kiyo. 2019;65:421-424.
    Abstract     Related articles   

  215. KIMURA H, Uemura Y, Megumi Y, Tachibana M, et al
    [A Case Of cT3bN2M0 Pleomorphic Giant Cell Carcinoma of the Bladder without Recurrence after Neoadjuvant Chemotherapy and Radical Cystectomy for 4 Years].
    Hinyokika Kiyo. 2019;65:377-380.
    Abstract     Related articles   

  216. LOU Y, Fan L, Hou X, Dominiczak AF, et al
    Paroxysmal Hypertension Associated With Urination.
    Hypertension. 2019 Sep 30:HYPERTENSIONAHA11913140.
    Abstract     Related articles   

  217. LOUARDI N, Elbahri A, Alami M, Ameur A, et al
    [Taeniasis and enterocystoplasty].
    Presse Med. 2019;48:987-989.
    Abstract     Related articles   

  218. KIRIGIN M, Lez C, Sarcevic B, Soipi S, et al
    Acta Clin Croat. 2019;58:180-182.
    Abstract     Related articles   

  219. ZHOU Q, Yu J, Zheng Q, Wu T, et al
    Kinesin family member 3A stimulates cell proliferation, migration, and invasion of bladder cancer cells in vitro and in vivo.
    FEBS Open Bio. 2019 Nov 27. doi: 10.1002/2211-5463.12768.
    Abstract     Related articles   

  220. ZHAO X, Li D, Zhao ST, Zhang Y, et al
    MiRNA-616 aggravates the progression of bladder cancer by regulating cell proliferation, migration and apoptosis through downregulating SOX7.
    Eur Rev Med Pharmacol Sci. 2019;23:9304-9312.
    Abstract     Related articles   

  221. XU S, Yao Q, Liu G, Jin D, et al
    Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer.
    Eur Radiol. 2019 Nov 26. pii: 10.1007/s00330-019-06484.
    Abstract     Related articles   

  222. YAJIMA K, Akise Y
    A Case Report of Graves' Disease Induced by the Anti-Human Programmed Cell Death-1 Monoclonal Antibody Pembrolizumab in a Bladder Cancer Patient.
    Case Rep Endocrinol. 2019;2019:2314032.
    Abstract     Related articles   

  223. CHEN L, Liu Y, Zhang Q, Zhang M, et al
    p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder Cancer.
    J Cancer. 2019;10:6207-6216.
    Abstract     Related articles   

  224. YAMASHITA H, Kawasawa YI, Shuman L, Zheng Z, et al
    Repression of transcription factor AP-2 alpha by PPARgamma reveals a novel transcriptional circuit in basal-squamous bladder cancer.
    Oncogenesis. 2019;8:69.
    Abstract     Related articles   

  225. WEI X, Yang X, Wang B, Yang Y, et al
    LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer.
    Cancer Med. 2019 Nov 25. doi: 10.1002/cam4.2684.
    Abstract     Related articles   

  226. WU S, Nitschke K, Heinkele J, Weis CA, et al
    ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data.
    Cancers (Basel). 2019;11.
    Abstract     Related articles   

  227. CHIANG Y, Wang CC, Tsai YC, Huang CY, et al
    Nuclear Factor-kappaB Overexpression is Correlated with Poor Outcomes after Multimodality Bladder-Preserving Therapy in Patients with Muscle-Invasive Bladder Cancer.
    J Clin Med. 2019;8.
    Abstract     Related articles   

  228. JIN H, Lin T, Han P, Yao Y, et al
    Efficacy of Raman spectroscopy in the diagnosis of bladder cancer: A systematic review and meta-analysis.
    Medicine (Baltimore). 2019;98:e18066.
    Abstract     Related articles   

  229. LI Y, Zu X, Hu X, Wang L, et al
    Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer.
    Med Sci Monit. 2019;25:8928-8939.
    Abstract     Related articles   

  230. ROSIELLO G, Palumbo C, Knipper S, Pecoraro A, et al
    Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer.
    Urol Oncol. 2019 Nov 21. pii: S1078-1439(19)30442.
    Abstract     Related articles   

  231. SLOAN FA, Yashkin AP, Akushevich I, Inman BA, et al
    Longitudinal patterns of cost and utilization of medicare beneficiaries with bladder cancer.
    Urol Oncol. 2019 Nov 21. pii: S1078-1439(19)30440.
    Abstract     Related articles   

  232. EROGLU A, Ekin RG, Koc G, Divrik RT, et al
    The prognostic value of routine second transurethral resection in patients with newly diagnosed stage pT1 non-muscle-invasive bladder cancer: results from randomized 10-year extension trial.
    Int J Clin Oncol. 2019 Nov 23. pii: 10.1007/s10147-019-01581.
    Abstract     Related articles   

  233. ALVAEUS J, Rosenblatt R, Johansson M, Alamdari F, et al
    Fewer tumour draining sentinel nodes in patients with progressing muscle invasive bladder cancer, after neoadjuvant chemotherapy and radical cystectomy.
    World J Urol. 2019 Nov 23. pii: 10.1007/s00345-019-03025.
    Abstract     Related articles   

  234. SHIMIZU T, Yamaguchi K, Yamamoto M, Kurioka R, et al
    Identification of HUHS190, a human naftopidil metabolite, as a novel anti-bladder cancer drug.
    Bioorg Med Chem Lett. 2019 Nov 8:126744. doi: 10.1016/j.bmcl.2019.126744.
    Abstract     Related articles   

  235. YANG D, Qian H, Fang Z, Xu A, et al
    Silencing circular RNA VANGL1 inhibits progression of bladder cancer by regulating miR-1184/IGFBP2 axis.
    Cancer Med. 2019 Nov 23. doi: 10.1002/cam4.2650.
    Abstract     Related articles   

  236. KONETY BR
    Intravesical Therapy for Nonmuscle Invasive Bladder Cancer: Twenty-First Century Edition.
    Urol Clin North Am. 2020;47:xiii.
    Abstract     Related articles   

  237. ARENDS TJH, Alfred Witjes J
    Apaziquone for Nonmuscle Invasive Bladder Cancer: Where Are We Now?
    Urol Clin North Am. 2020;47:73-82.
    Abstract     Related articles   

  238. FABA OR, Pisano F, Krajewski W, Breda A, et al
    Salvage Therapies for Non-muscle-invasive Bladder Cancer: Who Will Respond to Bacillus Calmette-Guerin? Predictors and Nomograms.
    Urol Clin North Am. 2020;47:5-13.
    Abstract     Related articles   

  239. COOLEY LF, McLaughlin KA, Meeks JJ
    Genomic and Therapeutic Landscape of Non-muscle-invasive Bladder Cancer.
    Urol Clin North Am. 2020;47:35-46.
    Abstract     Related articles   

  240. KHALED D, Taylor J, Holzbeierlein J
    Salvage Therapy for Non-muscle-invasive Bladder Cancer: Novel Intravesical Agents.
    Urol Clin North Am. 2020;47:119-128.
    Abstract     Related articles   

  241. CHU CE, Porten SP, Grossfeld GD, Meng MV, et al
    Role of Indoleamine-2,3-Dioxygenase Inhibitors in Salvage Therapy for Non-Muscle Invasive Bladder Cancer.
    Urol Clin North Am. 2020;47:111-118.
    Abstract     Related articles   

  242. SATHIANATHEN NJ, Regmi S, Gupta S, Konety BR, et al
    Immuno-Oncology Approaches to Salvage Treatment for Non-muscle invasive Bladder Cancer.
    Urol Clin North Am. 2020;47:103-110.
    Abstract     Related articles   

  243. ABULIZI R, Li B, Zhang CG
    Circ_0071662, a novel tumor biomarker, suppresses bladder cancer cell proliferation and invasion by sponging miR-146b-3p.
    Oncol Res. 2019 Nov 18. doi: 10.3727/096504019X15740729375088.
    Abstract     Related articles   

  244. SHEN J, Wu JF, Zhang J, Song ZQ, et al
    [An animal model of bladder reconstruction by autologous peritoneum transplantation].
    Zhonghua Wai Ke Za Zhi. 2019;57:853-859.
    Abstract     Related articles   

  245. KALDYBEKOV DB, Filippov SK, Radulescu A, Khutoryanskiy VV, et al
    Maleimide-functionalised PLGA-PEG nanoparticles as mucoadhesive carriers for intravesical drug delivery.
    Eur J Pharm Biopharm. 2019;143:24-34.
    Abstract     Related articles   

  246. SAKAMOTO A, Okamoto T, Ikeguchi R, Matsuda S, et al
    MRI examination of resected malignant bone tumor can be an option for assessment of the osseous surgical margin.
    Br J Radiol. 2019 Aug 6:20190518. doi: 10.1259/bjr.20190518.
    Abstract     Related articles   

  247. SHAN M, Zhang L, Liu Y, Gao C, et al
    DNA Methylation Profiles and Their Diagnostic Utility in BC.
    Dis Markers. 2019;2019:6328503.
    Abstract     Related articles   

  248. YAMAMICHI G, Nakata W, Tani M, Tsujimura G, et al
    High diagnostic efficacy of 5-aminolevulinic acid-induced fluorescent urine cytology for urothelial carcinoma.
    Int J Clin Oncol. 2019;24:1075-1080.
    Abstract     Related articles   

  249. ITO K, Kanno T, Sawada A, Saito R, et al
    Laparoscopic radical cystectomy in octogenarians: analysis of a Japanese multicenter cohort.
    Int J Clin Oncol. 2019;24:1081-1088.
    Abstract     Related articles   

  250. CHEN X, Kost J, Sulovari A, Wong N, et al
    A virome-wide clonal integration analysis platform for discovering cancer viral etiology.
    Genome Res. 2019;29:819-830.
    Abstract     Related articles   

  251. THE M, Kall L
    Integrated Identification and Quantification Error Probabilities for Shotgun Proteomics.
    Mol Cell Proteomics. 2019;18:561-570.
    Abstract     Related articles   

  252. GUPTA S, Albertson DJ, Parnell TJ, Butterfield A, et al
    Histone Deacetylase Inhibition Has Targeted Clinical Benefit in ARID1A-Mutated Advanced Urothelial Carcinoma.
    Mol Cancer Ther. 2019;18:185-195.
    Abstract     Related articles   

  253. SU Y, Du Z, Zhong G, Ya Y, et al
    circ5912 suppresses cancer progression via inducing MET in bladder cancer.
    Aging (Albany NY). 2019;11.
    Abstract     Related articles   

  254. CHEN M, Nie ZY, Wen XH, Gao YH, et al
    m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer.
    Biosci Rep. 2019 Dec 6. pii: 221434. doi: 10.1042/BSR20192892.
    Abstract     Related articles   

  255. IKEDA A, Nosato H, Kochi Y, Kojima T, et al
    Support system of cystoscopic diagnosis for bladder cancer based on artificial intelligence.
    J Endourol. 2019 Dec 6. doi: 10.1089/end.2019.0509.
    Abstract     Related articles   

  256. CHO CJ, Yang CW, Wu CL, Ho JY, et al
    The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrol.
    Oncol Lett. 2019;18:6869-6876.
    Abstract     Related articles   

  257. TAN S, Bian X, Wu B, Chen X, et al
    RASSF6 Is Downregulated In Human Bladder Cancers And Regulates Doxorubicin Sensitivity And Mitochondrial Membrane Potential Via The Hippo Signaling Pathway.
    Onco Targets Ther. 2019;12:9189-9200.
    Abstract     Related articles   

  258. WANG J, Tan X, Guo Q, Lin X, et al
    FGF9 inhibition by a novel binding peptide has efficacy in gastric and bladder cancer per se and reverses resistance to cisplatin.
    Pharmacol Res. 2019 Dec 2:104575. doi: 10.1016/j.phrs.2019.104575.
    Abstract     Related articles   

  259. SANGUEDOLCE F, Cormio L, Carrieri G, Calo B, et al
    Role of androgen receptor expression in non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
    Histol Histopathol. 2019 Dec 5:18189. doi: 10.14670.
    Abstract     Related articles   

  260. SATYAL U, Srivastava A, Abbosh PH
    Urine Biopsy-Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer.
    Front Oncol. 2019;9:1266.
    Abstract     Related articles   

  261. CASADEI C, Dizman N, Schepisi G, Cursano MC, et al
    Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors.
    Ther Adv Med Oncol. 2019;11:1758835919890285.
    Abstract     Related articles   

  262. LI Y, Chen R, Li Z, Cheng H, et al
    miR-204 Negatively Regulates Cell Growth And Metastasis By Targeting ROBO4 In Human Bladder Cancer.
    Onco Targets Ther. 2019;12:8515-8524.
    Abstract     Related articles   

  263. GUO Y, Yuan X, Li K, Dai M, et al
    GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.
    Cell Death Differ. 2019 Dec 4. pii: 10.1038/s41418-019-0466.
    Abstract     Related articles   

  264. WU S, Liu Y, Michalek JE, Mesa RA, et al
    Carotenoid Intake and Circulating Carotenoids Are Inversely Associated with the Risk of Bladder Cancer: A Dose-Response Meta-analysis.
    Adv Nutr. 2019 Dec 4. pii: 5652213. doi: 10.1093.
    Abstract     Related articles   

  265. YU X, Wang ZL, Han CL, Wang MW, et al
    LncRNA CASC15 functions as an oncogene by sponging miR-130b-3p in bladder cancer.
    Eur Rev Med Pharmacol Sci. 2019;23:9814-9820.
    Abstract     Related articles   

  266. LIM JH, Sundar S
    Prognosis of early stage small cell bladder cancer is not always dismal.
    ESMO Open. 2019;4:e000559.
    Abstract     Related articles   

  267. BA M, Cui S, Long H, Gong Y, et al
    Development of a high-precision bladder hyperthermic intracavitary chemotherapy device for bladder cancer and pharmacokinetic study.
    BMC Urol. 2019;19:126.
    Abstract     Related articles   

  268. LOPEZ-BELTRAN A, Cheng L, Gevaert T, Blanca A, et al
    Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers.
    Expert Rev Mol Diagn. 2019 Dec 4. doi: 10.1080/14737159.2020.1699791.
    Abstract     Related articles   

  269. ZHANG C, Shen K, Zheng Y, Qi F, et al
    Genome-wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer.
    Cancer Med. 2019 Dec 3. doi: 10.1002/cam4.2665.
    Abstract     Related articles   

  270. WISSING MD, Kassouf W, Tanguay S, Aprikian AG, et al
    The use of perioperative chemotherapy in patients undergoing radical cystectomy for bladder cancer in Quebec (Canada), 2000-2016.
    Can Urol Assoc J. 2019 Nov 29. pii: cuaj.6094. doi: 10.5489/cuaj.6094.
    Abstract     Related articles   

  271. PENG W, Dong N, Wu S, Gui D, et al
    miR-4500 suppresses cell proliferation and migration in bladder cancer via inhibition of STAT3/CCR7 pathway.
    J Cell Biochem. 2019 Dec 1. doi: 10.1002/jcb.29558.
    Abstract     Related articles   

  272. GUO J, Chen Z, Jiang H, Yu Z, et al
    The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/beta-catenin signaling pathway.
    Cancer Cell Int. 2019;19:312.
    Abstract     Related articles   

  273. LI X, Shu K, Zhou J, Yu Q, et al
    Preoperative Plasma Fibrinogen and D-dimer as Prognostic Biomarkers for Non-Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019 Nov 6. pii: S1558-7673(19)30329.
    Abstract     Related articles   

  274. RADKIEWICZ C, Edgren G, Johansson ALV, Jahnson S, et al
    Sex Differences in Urothelial Bladder Cancer Survival.
    Clin Genitourin Cancer. 2019 Nov 6. pii: S1558-7673(19)30324.
    Abstract     Related articles   

  275. D'ANDREA D, Soria F, Abufaraj M, Pones M, et al
    Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non-muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019 Nov 6. pii: S1558-7673(19)30325.
    Abstract     Related articles   

  276. LIU Y, Wu G
    NNT-AS1 enhances bladder cancer cell growth by targeting miR-1301-3p/PODXL axis and activating Wnt pathway.
    Neurourol Urodyn. 2019 Nov 29. doi: 10.1002/nau.24238.
    Abstract     Related articles   

  277. PACKIAM VT, Werntz RP, Steinberg GD
    Current Clinical Trials in Non-muscle-Invasive Bladder Cancer: Heightened Need in an Era of Chronic BCG Shortage.
    Curr Urol Rep. 2019;20:84.
    Abstract     Related articles   

  278. ARON M
    Variant Histology in Bladder Cancer-Current Understanding of Pathologic Subtypes.
    Curr Urol Rep. 2019;20:80.
    Abstract     Related articles   

  279. GURRAM S, Muthigi A, Egan J, Stamatakis L, et al
    Imaging in Localized Bladder Cancer: Can Current Diagnostic Modalities Provide Accurate Local Tumor Staging?
    Curr Urol Rep. 2019;20:82.
    Abstract     Related articles   

  280. BOSSHARD P, Roth B
    [Cisplatin-based chemotherapy in muscle-invasive bladder cancer: soon outdated ?]
    Rev Med Suisse. 2019;15:2190-2194.
    Abstract     Related articles   

  281. ZHANG N, Chen S, Wu L, Wu Y, et al
    Identification of Cancer-Specific Methylation of Gene Combination for the Diagnosis of Bladder Cancer.
    J Cancer. 2019;10:6761-6766.
    Abstract     Related articles   

  282. SONG Z, Zhang Q, Zhu J, Yin G, et al
    Identification of urinary hsa_circ _0137439 as potential biomarker and tumor regulator of bladder cancer.
    Neoplasma. 2019 Nov 18. pii: 181214N970. doi: 10.4149/neo_2018_181214.
    Abstract     Related articles   

  283. NARAYAN VM, Dinney CPN
    Intravesical Gene Therapy.
    Urol Clin North Am. 2020;47:93-101.
    Abstract     Related articles   

  284. BROOKS NA, O'Donnell MA
    Combination Intravesical Therapy.
    Urol Clin North Am. 2020;47:83-91.
    Abstract     Related articles   

  285. TAN WP, Longo TA, Inman BA
    Heated Intravesical Chemotherapy: Biology and Clinical Utility.
    Urol Clin North Am. 2020;47:55-72.
    Abstract     Related articles   

  286. HAAS CR, McKiernan JM
    Salvage Therapy Using Bacillus Calmette-Guerin Derivatives or Single Agent Chemotherapy.
    Urol Clin North Am. 2020;47:47-54.
    Abstract     Related articles   

  287. LI R, Kamat AM
    Predictors of Response to Intravesical Therapy.
    Urol Clin North Am. 2020;47:23-33.
    Abstract     Related articles   

  288. BECKER REN, Kates MR, Bivalacqua TJ
    Identification of Candidates for Salvage Therapy: The Past, Present, and Future of Defining Bacillus Calmette-Guerin Failure.
    Urol Clin North Am. 2020;47:15-21.
    Abstract     Related articles   

  289. KONETY BR, Narayan VM, Dinney CPN
    Bacillus Calmette-Guerin Salvage Therapy: Definitions and Context.
    Urol Clin North Am. 2020;47:1-4.
    Abstract     Related articles   

  290. SOUKUP V, Capoun O, Pesl M, Vavrova L, et al
    The significance of calprotectin, CD147, APOA4 and DJ-1 in non-invasive detection of urinary bladder carcinoma.
    Neoplasma. 2019;66:1019-1023.
    Abstract     Related articles   

  291. GIANNARINI G, Crestani A, Inferrera A, Rossanese M, et al
    Impact of enhanced recovery after surgery protocols versus standard of care on perioperative outcomes of radical cystectomy: a systematic review and meta-analysis of comparative studies.
    Minerva Urol Nefrol. 2019;71:309-323.
    Abstract     Related articles   

  292. HURLE R, Lazzeri M, Saita A, Naselli A, et al
    Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: pure versus non-pure CIS.
    Minerva Urol Nefrol. 2019;71:406-412.
    Abstract     Related articles   

  293. HSU YH, Huang HP, Chang HR
    The uremic toxin p-cresol promotes the invasion and migration on carcinoma cells via Ras and mTOR signaling.
    Toxicol In Vitro. 2019;58:126-131.
    Abstract     Related articles   

  294. ATAKA R, Sato S, Matsubara K, Takagi M, et al
    Small bowel obstruction due to internal hernia caused by the ureter after laparoscopic radical cystectomy and ileal conduit: A case report.
    Asian J Endosc Surg. 2019;12:189-191.
    Abstract     Related articles   

  295. SHAFIEIAN Z, Bahari G, Hashemi M, Nakhaee A, et al
    SIRT1 Gene Polymorphisms Are Associated with Urinary Bladder Cancer in an Iranian Population.
    Rep Biochem Mol Biol. 2019;8:194-199.
    Abstract     Related articles   

  296. RUAN H, Li Y, Wang X, Sun B, et al
    CRYAB inhibits migration and invasion of bladder cancer cells through the PI3K/AKT and ERK pathways.
    Jpn J Clin Oncol. 2019 Dec 12. pii: 5673759. doi: 10.1093.
    Abstract     Related articles   

  297. CHEN Q, Hu J, Deng J, Fu B, et al
    Bioinformatics Analysis Identified Key Molecular Changes in Bladder Cancer Development and Recurrence.
    Biomed Res Int. 2019;2019:3917982.
    Abstract     Related articles   

  298. VANTAKU V, Donepudi SR, Ambati CR, Jin F, et al
    Correction: Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer.
    Oncotarget. 2019;10:6843-6844.
    Abstract     Related articles   

  299. WANG J, Zhang H, Situ J, Li M, et al
    KCNQ1OT1 aggravates cell proliferation and migration in bladder cancer through modulating miR-145-5p/PCBP2 axis.
    Cancer Cell Int. 2019;19:325.
    Abstract     Related articles   

  300. ZAITSU M, Lee HE, Lee S, Takeuchi T, et al
    Occupational disparities in bladder cancer survival: A population-based cancer registry study in Japan.
    Cancer Med. 2019 Dec 11. doi: 10.1002/cam4.2768.
    Abstract     Related articles   

  301. JOSEPH M, Enting D
    Immune Responses in Bladder Cancer-Role of Immune Cell Populations, Prognostic Factors and Therapeutic Implications.
    Front Oncol. 2019;9:1270.
    Abstract     Related articles   

  302. LUO Y, Zeng G, Wu S
    Identification of Microenvironment-Related Prognostic Genes in Bladder Cancer Based on Gene Expression Profile.
    Front Genet. 2019;10:1187.
    Abstract     Related articles   

  303. SONPAVDE G, Necchi A, Gupta S, Steinberg GD, et al
    ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer.
    Future Oncol. 2019 Dec 11. doi: 10.2217/fon-2019-0611.
    Abstract     Related articles   

  304. ZIRAKZADEH AA, Sherif A, Rosenblatt R, Ahlen Bergman E, et al
    Tumour-associated B cells in urothelial urinary bladder cancer.
    Scand J Immunol. 2019 Dec 10:e12830. doi: 10.1111/sji.12830.
    Abstract     Related articles   

  305. CHEN S, Zhou Q, Guo Z, Wang Y, et al
    Inhibition of MELK produces potential anti-tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathway.
    J Cell Mol Med. 2019 Dec 10. doi: 10.1111/jcmm.14878.
    Abstract     Related articles   

  306. HE Q, Huang L, Yan D, Bi J, et al
    CircPTPRA acts as a tumor suppressor in bladder cancer by sponging miR-636 and upregulating KLF9.
    Aging (Albany NY). 2019;11.
    Abstract     Related articles   

  307. SU Y, Feng W, Zhong G, Ya Y, et al
    ciRs-6 upregulates March1 to suppress bladder cancer growth by sponging miR-653.
    Aging (Albany NY). 2019;11.
    Abstract     Related articles   

  308. MOHAMMED A, Miller MS, Lubet RA, Suen CS, et al
    Combination of erlotinib and naproxen employing pulsatile or intermittent dosing profoundly inhibits urinary bladder cancers.
    Cancer Prev Res (Phila). 2019 Dec 9. pii: 1940-6207.CAPR-19-0339.
    Abstract     Related articles   

  309. YOON HY, Yang HM, Kim CH, Goo YT, et al
    Enhanced Intracellular Delivery of BCG Cell Wall Skeleton into Bladder Cancer Cells Using Liposomes Functionalized with Folic Acid and Pep-1 Peptide.
    Pharmaceutics. 2019;11.
    Abstract     Related articles   

  310. POLIKARPOV D, Liang L, Care A, Sunna A, et al
    Functionalized Upconversion Nanoparticles for Targeted Labelling of Bladder Cancer Cells.
    Biomolecules. 2019;9.
    Abstract     Related articles   

  311. YAO Z, Zheng Z, Ke W, Wang R, et al
    Prognostic nomogram for bladder cancer with brain metastases: a National Cancer Database analysis.
    J Transl Med. 2019;17:411.
    Abstract     Related articles   

  312. LI F, Su M, Zhao H, Xie W, et al
    HnRNP-F promotes cell proliferation by regulating TPX2 in bladder cancer.
    Am J Transl Res. 2019;11:7035-7048.
    Abstract     Related articles   

  313. WEI Y, Zhang Y, Meng Q, Cui L, et al
    Hypoxia-induced circular RNA has_circRNA_403658 promotes bladder cancer cell growth through activation of LDHA.
    Am J Transl Res. 2019;11:6838-6849.
    Abstract     Related articles   

  314. GRIVAS P, Bismar TA, Alva AS, Huang HC, et al
    Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy.
    Urol Oncol. 2019 Dec 4. pii: S1078-1439(19)30459.
    Abstract     Related articles   

  315. YI S, Park H
    A rare case of aquaporin-4-antibody-positive neuromyelitis optica associated with bladder cancer.
    Mult Scler Relat Disord. 2019;38:101499.
    Abstract     Related articles   

  316. BULKLEY JE, O'Keeffe-Rosetti M, Wendel CS, Davis JV, et al
    The effect of multiple recruitment contacts on response rates and patterns of missing data in a survey of bladder cancer survivors 6 months after cystectomy.
    Qual Life Res. 2019 Dec 6. pii: 10.1007/s11136-019-02379.
    Abstract     Related articles   

  317. CRISPEN PL, Kusmartsev S
    Mechanisms of immune evasion in bladder cancer.
    Cancer Immunol Immunother. 2019 Dec 6. pii: 10.1007/s00262-019-02443.
    Abstract     Related articles   

  318. XU J, Hua X, Yang R, Jin H, et al
    XIAP Interaction with E2F1 and Sp1 via its BIR2 and BIR3 domains specific activated MMP2 to promote bladder cancer invasion.
    Oncogenesis. 2019;8:71.
    Abstract     Related articles   

  319. MONTAZERI K, Bellmunt J
    Erdafitinib for the treatment of metastatic bladder cancer.
    Expert Rev Clin Pharmacol. 2019 Dec 6. doi: 10.1080/17512433.2020.1702025.
    Abstract     Related articles   

  320. MANI J, Fleger J, Rutz J, Maxeiner S, et al
    Curcumin combined with exposure to visible light blocks bladder cancer cell adhesion and migration by an integrin dependent mechanism.
    Eur Rev Med Pharmacol Sci. 2019;23:10564-10574.
    Abstract     Related articles   

  321. VARTOLOMEI L, Vartolomei MD, Shariat SF
    Bladder Cancer: Depression, Anxiety, and Suicidality Among the Highest-risk Oncology Patients.
    Eur Urol Focus. 2019 Dec 10. pii: S2405-4569(19)30330.
    Abstract     Related articles   

  322. LV S, Yu J, Zhao Y, Li H, et al
    A Microfluidic Detection System for Bladder Cancer Tumor Cells.
    Micromachines (Basel). 2019;10.
    Abstract     Related articles   

  323. LIU J, Li S, Cheng X, DU P, et al
    HOXB2 is a Putative Tumour Promotor in Human Bladder Cancer.
    Anticancer Res. 2019;39:6915-6921.
    Abstract     Related articles   

  324. DHARIWAL R, Pindoria N, Dasgupta P, Khan MS, et al
    #Checkmate: could checkpoint inhibitors be the game changer in the fight against metastatic urothelial carcinoma?
    BJU Int. 2019;123:203-207.
    Abstract     Related articles   

  325. NURMINEN P, Ettala O, Seppanen M, Taimen P, et al
    Urine cytology is a feasible tool for assessing erythematous bladder lesions after bacille Calmette-Guerin (BCG) treatment.
    BJU Int. 2019;123:246-251.
    Abstract     Related articles   

  326. KINNEAR N, O'Callaghan M, Hennessey D, Liddell H, et al
    Intra-operative cell salvage in urological surgery: a systematic review and meta-analysis of comparative studies.
    BJU Int. 2019;123:210-219.
    Abstract     Related articles   

  327. TAYLOR J, Becher E, Steinberg GD
    Update on the Guideline of Guidelines: Non-Muscle Invasive Bladder Cancer.
    BJU Int. 2019 Oct 9. doi: 10.1111/bju.14915.
    Abstract     Related articles   

  328. KHETRAPAL P, Kelly JD, Catto JWF, Vasdev N, et al
    Does the robot have a role in radical cystectomy?
    BJU Int. 2019;123:380-382.
    Abstract     Related articles   

  329. KITA Y, Hamada A, Saito R, Teramoto Y, et al
    Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies.
    Br J Cancer. 2019 Nov 1. pii: 10.1038/s41416-019-0609.
    Abstract     Related articles   

  330. FLETCHER SA, Cole AP, Lu C, Marchese M, et al
    The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years.
    Cancer. 2019 Oct 18. doi: 10.1002/cncr.32562.
    Abstract     Related articles   

  331. CUI H, Tang M, Zhang M, Liu S, et al
    Variants in the PSCA gene associated with risk of cancer and nonneoplastic diseases: systematic research synopsis, meta-analysis and epidemiological evidence.
    Carcinogenesis. 2019;40:70-83.
    Abstract     Related articles   

  332. SOTTNIK JL, Mallaredy V, Chauca-Diaz A, Ritterson Lew C, et al
    Elucidating the role of Agl in bladder carcinogenesis by generation and characterization of genetically engineered mice.
    Carcinogenesis. 2019;40:194-201.
    Abstract     Related articles   

  333. GRIVAS P
    DNA Damage Response Gene Alterations in Urothelial Cancer: Ready for Practice?
    Clin Cancer Res. 2019;25:907-909.
    Abstract     Related articles   

  334. KATES M, Matoso A, Choi W, Baras AS, et al
    Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG Unresponsive Trials.
    Clin Cancer Res. 2019 Nov 11. pii: 1078-0432.CCR-19-1920.
    Abstract     Related articles   

  335. MORI K, D'Andrea D, Enikeev DV, Egawa S, et al
    En bloc resection for nonmuscle invasive bladder cancer: review of the recent literature.
    Curr Opin Urol. 2019 Nov 12. doi: 10.1097/MOU.0000000000000697.
    Abstract     Related articles   

  336. KETTUNEN K, Bostrom P, Taimen P
    Reply to Xuefeng Liu's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol. In press. https://do
    Eur Urol. 2019 Sep 26. pii: S0302-2838(19)30731.
    Abstract     Related articles   

  337. LIU X
    Re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.06.016: Can Patie
    Eur Urol. 2019 Sep 26. pii: S0302-2838(19)30734.
    Abstract     Related articles   

  338. KAMOUN A, Reynies A, Allory Y, Sjodahl G, et al
    A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Sep 25. pii: S0302-2838(19)30695.
    Abstract     Related articles   

  339. LEOW JJ, Catto JWF, Efstathiou JA, Gore JL, et al
    Quality Indicators for Bladder Cancer Services: A Collaborative Review.
    Eur Urol. 2019 Sep 25. pii: S0302-2838(19)30690.
    Abstract     Related articles   

  340. KRIEGMAIR MC, Rother J, Grychtol B, Theuring M, et al
    Multiparametric Cystoscopy for Detection of Bladder Cancer Using Real-time Multispectral Imaging.
    Eur Urol. 2019 Sep 26. pii: S0302-2838(19)30674.
    Abstract     Related articles   

  341. YATAI KB, Tran H, Dunning MJ, Wang D, et al
    Sources of Bias Within Consensus Subtypes of Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Oct 23. pii: S0302-2838(19)30760.
    Abstract     Related articles   

  342. DEL GIUDICE F, Barchetti G, De Berardinis E, Pecoraro M, et al
    Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Eur Urol. 2019 Nov 4. pii: S0302-2838(19)30757.
    Abstract     Related articles   

  343. WITJES JA, Babjuk M, Bellmunt J, Bruins HM, et al
    EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort(dagger): Under the Auspices of the EAU-ESMO Guidelines Committees.
    Eur Urol. 2019 Nov 16. pii: S0302-2838(19)30763.
    Abstract     Related articles   

  344. WILLIAMS SB, Black PC, Dyrskjot L, Seiler R, et al
    Re: Aurelie Kamoun, Aurelien de Reynies, Yves Allory, et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.09.006: A Statement from the International Bladder Cancer Ne
    Eur Urol. 2019 Nov 28. pii: S0302-2838(19)30874.
    Abstract     Related articles   

  345. THIBAULT C, Lavaud P, Loriot Y
    Studying Rarity in Bladder Cancer.
    Eur Urol. 2019 Dec 4. pii: S0302-2838(19)30891.
    Abstract     Related articles   

  346. ZENG H, Liu Z, Wang Z, Zhou Q, et al
    Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32715.
    Abstract     Related articles   

  347. JACK S, Madhivanan K, Ramadesikan S, Subramanian S, et al
    A Novel, Safe, Fast, Efficient Treatment for Her2-positive and Negative Bladder Cancer Utilizing an EGF-Anthrax Toxin Chimera.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32719.
    Abstract     Related articles   

  348. XU M, Gu M, Zhou J, Da J, et al
    Interaction of YAP1 and mTOR promotes bladder cancer progression.
    Int J Oncol. 2019 Nov 25. doi: 10.3892/ijo.2019.4922.
    Abstract     Related articles   

  349. LIN F, Yin HB, Li XY, Zhu GM, et al
    Bladder cancer cellsecreted exosomal miR21 activates the PI3K/AKT pathway in macrophages to promote cancer progression.
    Int J Oncol. 2019 Dec 3. doi: 10.3892/ijo.2019.4933.
    Abstract     Related articles   

    Editorial Comment from Dr Matsumoto to Intraoperative hypotension caused by oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer.
    Int J Urol. 2019 Oct 6. doi: 10.1111/iju.14131.
    Abstract     Related articles   

    Editorial Comment from Dr Fukuhara to Intraoperative hypotension caused by oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer.
    Int J Urol. 2019 Oct 11. doi: 10.1111/iju.14124.
    Abstract     Related articles   

  352. KIKUCHI E, Hayakawa N, Fukumoto K, Shigeta K, et al
    Bacillus Calmette-Guerin-unresponsive non-muscle-invasive bladder cancer: Its definition and future therapeutic strategies.
    Int J Urol. 2019 Dec 3. doi: 10.1111/iju.14153.
    Abstract     Related articles   

  353. GORGEL SN, Akin Y, Koc EM, Kose O, et al
    Retrospective study of systemic immune-inflammation index in muscle invasive bladder cancer: initial results of single centre.
    Int Urol Nephrol. 2019 Oct 28. pii: 10.1007/s11255-019-02325.
    Abstract     Related articles   

  354. GULLU AMURAN G, Tinay I, Filinte D, Ilgin C, et al
    Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls.
    Int Urol Nephrol. 2019 Nov 2. pii: 10.1007/s11255-019-02328.
    Abstract     Related articles   

  355. OTTOSSON K, Pelander S, Johansson M, Huge Y, et al
    The increased risk for thromboembolism pre-cystectomy in patients undergoing neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer is mainly due to central venous access: a multicenter evaluation.
    Int Urol Nephrol. 2019 Nov 19. pii: 10.1007/s11255-019-02338.
    Abstract     Related articles   

  356. YAMASHITA R, Nakamura M, Notsu A, Hashizume A, et al
    The occurrence of high-grade complications after radical cystectomy worsens oncological outcomes in patients with bladder cancer.
    Int Urol Nephrol. 2019 Nov 22. pii: 10.1007/s11255-019-02341.
    Abstract     Related articles   

  357. LIEM EI, Oddens JR, Vernooij R, Li R, et al
    The Role of Fluorescence in Situ Hybridization for Predicting Recurrence after Adjuvant Bacillus Calmette-Guerin in Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer Patients: A Systematic Review and Meta-Analysis of Individual Patient Da
    J Urol. 2019 Sep 24:101097JU0000000000000566. doi: 10.1097/JU.0000000000000566.
    Abstract     Related articles   

  358. CHANG SS
    Re: Occupation and Bladder Cancer Phenotype: Identification of Workplace Patterns That Increase the Risk of Advanced Disease beyond Overall Incidence.
    J Urol. 2019 Oct 16:101097JU0000000000000599. doi: 10.1097/JU.0000000000000599.
    Abstract     Related articles   

  359. RITCH CR, Velasquez MC, Kwon D, Becerra MF, et al
    Utility and Validation of the AUA/SUO Risk Grouping for Non-muscle Invasive Bladder Cancer in a Contemporary Cohort.
    J Urol. 2019 Oct 14:101097JU0000000000000593. doi: 10.1097/JU.0000000000000593.
    Abstract     Related articles   

  360. MONTORSI F, Moschini M, Briganti A
    Re: Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guerin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial.
    J Urol. 2019 Oct 24:101097JU0000000000000624. doi: 10.1097/JU.0000000000000624.
    Abstract     Related articles   

  361. LOTAN Y
    Re: Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guerin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial.
    J Urol. 2019 Oct 25:101097JU0000000000000625. doi: 10.1097/JU.0000000000000625.
    Abstract     Related articles   

  362. WEIN AJ
    Re: Long-Term Follow-Up after Cystectomy for Bladder Pain Syndrome: Pain Status, Sexual Function and Quality of Life.
    J Urol. 2019;202:1101-1102.
    Abstract     Related articles   

  363. LENIS AT
    Editorial Comment.
    J Urol. 2019;202:1134-1135.
    Abstract     Related articles   

  364. ALBERSHEIM J, Sathianathen NJ, Zabell J, Renier J, et al
    Skeletal Muscle and Fat Mass Indexes Predict Discharge Disposition after Radical Cystectomy.
    J Urol. 2019;202:1143-1149.
    Abstract     Related articles   

  365. SIGHINOLFI MC, Rocco B, Micali S, Bianchi G, et al
    Re: Accurate Quantification of Residual Cancer Cells in Pelvic Washing Reveals Association with Cancer Recurrence following Robot-Assisted Radical Cystectomy.
    J Urol. 2019;202:1271-1272.
    Abstract     Related articles   

  366. RASKOLNIKOV D, Brown B, Holt SK, Ball AL, et al
    Reduction of Pain during Flexible Cystoscopy: A Systematic Review and Meta-Analysis.
    J Urol. 2019;202:1136-1142.
    Abstract     Related articles   

  367. LABBATE C, Werntz RP, Adamic B, Steinberg GD, et al
    The Impact of Omission of Intraoperative Frozen Section Prior to Orthotopic Neobladder Reconstruction.
    J Urol. 2019;202:763-769.
    Abstract     Related articles   

  368. AL HUSSEIN AL AWAMLH B, Shoag JE, Ravikumar V, Posada L, et al
    Association of Smoking and Death from Genitourinary Malignancies: Analysis of the National Longitudinal Mortality Study.
    J Urol. 2019;202:1248-1254.
    Abstract     Related articles   

  369. CHANG SS
    Re: Radiofrequency-Induced Thermo-Chemotherapy Effect versus a Second Course of Bacillus Calmette-Guerin or Institutional Standard in Patients with Recurrence of Non-Muscle-Invasive Bladder Cancer following Induction or Maintenance Bacillus Calmette-G
    J Urol. 2019 Dec 3:101097JU0000000000000676. doi: 10.1097/JU.0000000000000676.
    Abstract     Related articles   

  370. SINGLA N
    Editorial Comment.
    J Urol. 2019;202:688.
    Abstract     Related articles   

    Re: Reduced Recurrence of Low-Grade Papillary Bladder Tumors Associated with Asymptomatic Bacteriuria.
    J Urol. 2019;202:849.
    Abstract     Related articles   

  372. ATALA A
    Re: Recurrent Activating Mutations of PPARgamma Associated with Luminal Bladder Tumors.
    J Urol. 2019;202:869.
    Abstract     Related articles   

  373. SEFIK E, Bozkurt IH, Basmaci I, Celik S, et al
    Re: Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled Trial.
    J Urol. 2019;202:819.
    Abstract     Related articles   

  374. LUO Y, Wang X, Xiao Y
    Re: Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled Trial.
    J Urol. 2019;202:819-820.
    Abstract     Related articles   

  375. STEINBERG RL, Thomas LJ, Brooks N, Mott SL, et al
    Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy of Non-muscle Invasive Bladder Cancer.
    J Urol. 2019 Dec 10:101097JU0000000000000688. doi: 10.1097/JU.0000000000000688.
    Abstract     Related articles   

  376. OSEI-AMPONSA V, Buckwalter JM, Shuman L, Zheng Z, et al
    Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancer.
    Oncogene. 2019 Oct 21. pii: 10.1038/s41388-019-1063.
    Abstract     Related articles   

  377. LIU F, Zhang H, Xie F, Tao D, et al
    Hsa_circ_0001361 promotes bladder cancer invasion and metastasis through miR-491-5p/MMP9 axis.
    Oncogene. 2019 Nov 8. pii: 10.1038/s41388-019-1092.
    Abstract     Related articles   

  378. YANG R, Xu J, Hua X, Tian Z, et al
    Overexpressed miR-200a promotes bladder cancer invasion through direct regulating Dicer/miR-16/JNK2/MMP-2 axis.
    Oncogene. 2019 Nov 26. pii: 10.1038/s41388-019-1120.
    Abstract     Related articles   

  379. NEUZILLET Y, Geiss R, Paillaud E, Mongiat-Artus P, et al
    [Optimizing the management of bladder cancer in older patients].
    Prog Urol. 2019;29:849-864.
    Abstract     Related articles   

  380. MARQUETTE T, Walz J, Rybikowski S, Maubon T, et al
    [Safety of Hyperthermic IntraVEsical Chemotherapy (HIVEC) for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients].
    Prog Urol. 2019 Nov 28. pii: S1166-7087(19)30609.
    Abstract     Related articles   

  381. FRAISSE G, Renard Y, Lebacle C, Masson-Lecomte A, et al
    [Is sarcopenia a morbi-mortality factor in the treatment of localized muscle-invasive bladder cancer?]
    Prog Urol. 2019 Dec 6. pii: S1166-7087(19)30610.
    Abstract     Related articles   

  382. JEGLINSCHI S, Schirmann A, Durand M, Sanchez S, et al
    Factors affecting guideline adherence in the initial treatment of non-muscle invasive bladder cancer: Retrospective study in a French peripheral hospital.
    Prog Urol. 2019 Dec 5. pii: S1166-7087(19)30611.
    Abstract     Related articles   

  383. HAUTMANN RE, Bolenz C, Volkmer B
    Unexpected Early Oncologic Mortality after Open Radical Cystectomy for Bladder Cancer: Who Is to Be Blamed?
    Urol Int. 2019 Sep 27:1-6. doi: 10.1159/000503398.
    Abstract     Related articles   

  384. FROEHNER M, Muallah D, Koch R, Hubler M, et al
    Socioeconomic Status-Related Parameters as Predictors of Competing (Non-Bladder Cancer) Mortality after Radical Cystectomy.
    Urol Int. 2019 Oct 22:1-8. doi: 10.1159/000502781.
    Abstract     Related articles   

  385. ZIEGELMUELLER BK, Jokisch JF, Buchner A, Grimm T, et al
    Long-Term Follow-Up and Oncological Outcome of Patients Undergoing Radical Cystectomy for Bladder Cancer following an Enhanced Recovery after Surgery (ERAS) Protocol: Results of a Large Randomized, Prospective, Single-Center Study.
    Urol Int. 2019 Dec 4:1-7. doi: 10.1159/000504236.
    Abstract     Related articles   

  386. ALBARAKATI N, Khayyat D, Dallol A, Al-Maghrabi J, et al
    The prognostic impact of GSTM1/GSTP1 genetic variants in bladder Cancer.
    BMC Cancer. 2019;19:991.
    Abstract     Related articles   

  387. ZHANG J, Wang Y, Weng H, Wang D, et al
    Management of non-muscle-invasive bladder cancer: quality of clinical practice guidelines and variations in recommendations.
    BMC Cancer. 2019;19:1054.
    Abstract     Related articles   

  388. MOLENAAR RJ, van Hattum JW, Brummelhuis IS, Oddens JR, et al
    Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer.
    BMC Cancer. 2019;19:1133.
    Abstract     Related articles   

  389. ZENG S, Liu A, Dai L, Yu X, et al
    Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms.
    BMC Cancer. 2019;19:604.
    Abstract     Related articles   

  390. WANG Z, Liu X, Liu X, Sun H, et al
    UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma.
    BMC Cancer. 2019;19:1195.
    Abstract     Related articles   

  391. BOURN J, Rathore K, Donnell R, White W, et al
    Detection of carcinogen-induced bladder cancer by fluorocoxib A.
    BMC Cancer. 2019;19:1152.
    Abstract     Related articles   

  392. FANG CW, Hsieh VC, Huang SK, Tsai IJ, et al
    A population-based cohort study examining the association of documented bladder diverticulum and bladder cancer risk in urology patients.
    PLoS One. 2019;14:e0222875.
    Abstract     Related articles   

  393. KIM MJ, Chi BH, Yoo JJ, Ju YM, et al
    Structure establishment of three-dimensional (3D) cell culture printing model for bladder cancer.
    PLoS One. 2019;14:e0223689.
    Abstract     Related articles   

  394. GRIFFITHS GO, Cowan RA, Grigor KM, Uscinska BM, et al
    BA08: An open-label, single-arm, non-randomised, phase 2 trial of cisplatin, methotrexate and vinblastine (CMV) for pure squamous cell cancer of the urinary tract.
    PLoS One. 2019;14:e0210785.
    Abstract     Related articles   

  395. GOFRIT ON, Klein BY, Cohen IR, Ben-Hur T, et al
    Bacillus Calmette-Guerin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients.
    PLoS One. 2019;14:e0224433.
    Abstract     Related articles   

  396. HE S, Carman CV, Lee JH, Lan B, et al
    The tumor suppressor p53 can promote collective cellular migration.
    PLoS One. 2019;14:e0202065.
    Abstract     Related articles   

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.